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Carotenoids and Dietary Lipids in Health and Disease
International Conference
finalizing the DLARFID project
(QLRT-2001-00183)
Kraków, 9–12 December 2004
VENUE: Collegium Novum
The Jagiellonian University
Kraków, Gołębia 24 Str.
The DLARFID Conference is held under the patronage of:
Professor Franciszek Ziejka
The Rector Magnificus of The Jagiellonian University
Professor Maria Nowakowska
The Vice-Rector of The Jagiellonian University for Research and International Relations
Professor Marek Zembala
The Vice-Rector of The Jagiellonian University for the Medical College
With invitation of the Presidents of the Societies:
European Atherosclerosis Society (EAS) — prof. Michał Tendera
Polish Angiological Society — prof. Wojciech Witkiewicz
Polish Atherosclerosis Society — prof. Marek Naruszewicz
Polish Biochemical Society — prof. Jolanta Barańska
Polish Cardiac Society — prof. Andrzej Januszewicz
Polish Society of Diabetology — prof. Jacek Sieradzki
Polish Society for Endocrinology — prof. Andrzej Lewiński
Polish Society of Hematology — prof. Wiktor Jędrzejczak
Polish Society of Hypertension — prof. Jerzy Głuszek
Polish Society of Nutritional Sciences — prof. Anna-Gronowska-Senger
Polish Scientific Society for Obesity and Metabolism — prof. Barbara Zahorska-Markiewicz
Polish Union of Oncology — dr. Janusz Meder
Polish Society for Pathogenesis and Therapy of Obesity — prof. Andrzej Milewicz
Postgraduate School of Molecular Medicine — prof. Liliana Konarska
Sponsorship:
FP5 DLARFID (QLK1-CT-2001-00183) “Dietary Lipids as Risk Factors in Development. Mechanistic Issues”
FP5 STEC (QLK3-CT-2002-30307) “Stem Cell Therapeutics Excellence Center”
COST-B17 “Insulin resistance, obesity and diabetes mellitus in the elderly”
FP6-2002-FOOD 506360 NuGO “European Nutrigenomics Organisation — Linking genomics, nutrition
    and health research”
156/E-390/SP/MSN/P-05/DWM 565 “The New Technology in Medicine Center — Stem Cells Network
    of Excellence”
DSM Nutritional Products (Basel) Switzerland
Roche Diagnostics Polska sp. z.o.o
Novartis Poland sp. z.o.o
Perlan Technologies sp. z o.o.
Media coverage:
Telewizja Polska S.A. (TVP)
Carotenoids and Dietary Lipids in Health and disease
International DLARFID Conference
LOCAL SCIENTIFIC BOARD JAGIELLONIAN UNIVERSITY, KRAKÓW, POLAND
Prof. Aldona Dembińska-Kieć
Department of Clinical Biochemistry, Medical Faculty
Prof. Piotr Laidler
Institute of Medical Biochemistry, Medical Faculty
Prof. Aleksander B. Skotnicki
Chair and Clinic of Haematology, Medical Faculty
Prof. Kazimierz Strzałka
Department of Plant Physiology and Biochemistry, Faculty of Biotechnology
INTERNATIONAL SCIENTIFIC BOARD — THE DLARFID CONSORTIUM MEMBERS
Prof. Saverio Cinti
Faculty of Medicine, University of Ancona, Ancona (Italy)
Dr. Regina Goralczyk
DSM Nutritional Products, Basel (Switzerland)
Prof. Karsten Kristiansen
Department of Biochemistry and Molecular Biology, University of Southern Denmark,
Odense (Denmark)
Dr. Jaap Keijer
Department of Molecular Biology, The State Institute for Quality Control of Agricultural
Products (RIKILT), Wageningen (The Netherlands)
Prof. Jan Nedergaard
Department of Molecular Physiology, The Wenner-Gren Institute, Stockholm University,
Stockholm (Sweden)
Prof. Andreu Palou
Department of Fundamental Biology and Health Sciences, University of Balearic Islands,
Majorca  (Spain)
Prof. Gerd Schmitz
Institute for Clinical Chemistry and Laboratory Medicine, University of Regensburg,
Regensburg (Germany)
Dear Colleagues
The nutrients, including fatty acids and lipid-soluble vitamins including Vit A, or its precursors,
are essential for the development and tissue organization in any period of our life. They directly
and indirectly regulate different bioactive substances gene expression, which is important for energy
production, but also for cellular maturation and functional remodeling of the tissue including adipose
tissue, muscle, vasculature etc.
Unfortunately, similar cellular mechanisms are involved in deep pathology of diet-mediated social
life-threatening illnesses such as: the induction of obesity (differentiation of adipocytes), glucose
and lipid intolerance (diabetes and arteriosclerosis), cancer (proliferation of non-differentiated cells)
and pathological angiogenesis (cancer, arteriosclerosis), all of which impair social and health care
benefits.
The fifth EU Framework DLARFID (Dietary Lipids as Risk Factor in Development Mechanistic
Issues) was aimed at linking consumer hazards and understanding the role of nutrients such as fatty
acids and carotenoids in health and disease.
This Symposium, organized at the end of the cooperation in frame of this project, offer
the unique opportunity to bring together renomed experts (including representatives of the other
EU Commission projects such as NuGO, LIPGENE and COST 17B Action) and young scientists
(The Postgraduate School of Molecular Medicine (SMM)) to discuss the results, as well as build an
international platform of nutrigenomic research in Europe.
The charming atmosphere of medieval Kraków, preparing for Christmas, is waiting for you...
We look forward to light the candles and sing Christmas Carols with you...
On behalf of the DLARFID consortium
Aldona Dembińska-Kieć
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General  program
Thursday, 9 December 2004
C O L L E G I U M  N O V U M  ( S A L A  S E N A C K A )
9.00–15.00 THE DLARFID CONSORTIUM MEETING
for members DLAFRID Consortium only
C O L L E G I U M  N O V U M  ( A U L A )
18:00 OPENING CEREMONY
19:00 FIRST PLENARY LECTURE
Fatty acid composition of fats as an early determinant of childhood obesity
Gerard Ailhaud (France)
20:00 W e l c o m e   c o c k t a i l  (Collegium Novum)
Friday, 10 December 2004
C O L L E G I U M  N O V U M  ( A U L A )
SESSION I
LIPIDS AND CAROTENOIDS. SOURCES, METABOLISM AND MECHANISMS
OF GENOMIC AND NON-GENOMIC ACTIONS
Chairmen: Sue Southon, Saverio Cinti
08:45 Challenges to understanding and measuring carotenoid bioavailability
Sue Southon (United Kingdom)
09:25 Fatty acids and expression of adipokines
Christian A. Drevon (Norway)
10:05 Structurally different marine oils in health and disease
Livar Froyland (Norway)
10:45–11:00 C o f f e e  b r e a k
11:00 Mechanisms of genomic and non-genomic actions of lipids and carotenoids
Ruan Elliott (United Kingdom)
11:40 Towards a better understanding of carotenoid metabolism in animals
Johannes von Lintig (Germany)
12:20 Morphology of ferret subcutaneous adipose tissue after six-month daily
supplementation with oral beta-carotene
Saverio Cinti, Manrico Morroni (Italy)
13:00–14:00 L u n c h  b r e a k  (Zodiak Hall, Œw. Anny 12 Str.)
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SESSION IIA
CAROTENOIDS AND LIPIDS IN CELL PROLIFERATION AND DIFFERENTIATION
(NORMAL CELLS)
Chairmen: Gerd Schmitz, Andreu Palou
14:00 Gene regulation by beta-carotene in ferrets
Andreu Palou (Spain)
14:30 Gene expression profiling identifies retinoids as potent inducers of macrophage
lipid efflux
Gerd Schmitz, Thomas Langmann (Germany)
15:00 Vitamin A as a regulator of adipogenesis and adipocyte metabolism-derived
medical complications
Andreu Palou, María Luisa Bonet (Spain)
15:30 Transgenic embryonic stem cells for basic research and clinical application
Jürgen Hescheler (Germany)
16:00 –16:15 C o f f e e  b r e a k
Chairmen: Jan Nedergaard, Karsten Kristiansen
16:15 PPARg in the control of brown adipocyte differentiation
Jan Nedergaard (Sweden)
16:45 Regulation of adipocyte differentiation and function by polyunsaturated fatty acid
Lise Madsen (Norway/Denmark)
17:15 Molecular mechanisms controlling white versus brown adipocyte differentiation
Karsten Kristiansen (Denmark)
17:45 Umbilical cord progenitor cell differentiation in the presence of PPAR-gamma
and RAR/RXR activators
Aldona Dembiñska-Kieæ (Poland)
19:30 G a l a  D i n n e r  (Pokutynski Palace, Karmelicka 29 Str.)
Saturday, 11 December 2004
C O L L E G I U M  N O V U M  ( A U L A )
SESSION IIB
CAROTENOIDS AND LIPIDS IN CELL PROLIFERATION AND DIFFERENTIATION
(CANCER CELLS)
Chairmen: Jaap Keijer, Piotr Laidler
08:45 Effects of b-carotene and lycopene in cells exposed to cigarette smoke condensate:
modulation of redox sensitive molecular pathways involved in cell growth
Paola Palozza (Italy)
09:15 b-carotene-induced changes in RARb isoform expression pattern do not influence
lung adenoma multiplicity in the NNK-initiated A/J mouse model
Regina Goralczyk (Switzerland)
09:45 The effect of b-carotene in colon and lung epithelial cells
Jaap Keijer (The Netherlands)
11www.angiologia.pl
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10:15 The effect of beta-carotene and fatty acids on proliferation and apoptosis of human
melanoma and prostate cancer cells
Piotr Laidler (Poland)
10:45–11:00 C o f f e e  b r e a k
Chairmen: Maria Stacewicz-Sapuntzakis, John S. Bertram
11:00 Role of lycopene and tomato products in prostate health
Maria Stacewicz-Sapuntzakis, Phyllis E. Bowen (United States of America)
11:30 The in vitro effect of  b-carotene and arachidonic acid on cytotoxicity, proliferative
potential, differentiation and apoptosis on the acute myeloid leukemia cells
Aleksander B. Skotnicki, Tomasz Sacha, Gerd Schmitz, Thomas Langmann (Poland, Germany)
12:00 Cancer prevention by retinoids and carotenoids: independent action
on a common target
John S. Bertram (United States of America)
C O L L E G I U M  N O V U M  (HALL)
12.30–14.00 POSTER SESSION
I. Cell differentiation (signal transduction)
1. Prostate cancer and supplementation with fatty acid and beta-carotene:
cell cycle regulation
J. Duliñska, P. Laidler, D. Gil, W. Placha, A. Dembiñska-Kieæ, G. Schmitz
2. Different effect of beta-carotene on proliferation of prostate cancer cells
J. Duliñska, D. Gil, J. Zagajewski, J. Hartwich, M. Bodzioch, A. Kieæ-Dembiñska,
T. Langmann, G. Schmitz, P. Laidler
3. The effect of arachidonic acid and beta-carotene on human melanoma cell
growth
D. Gil, W. Placha, J. Duliñska, A. Kieæ-Dembiñska, G. Schmitz, P. Laidler
4. Retinoid signaling promoted by apocarotenals and beta-carotene in BEAS-2B
human bronchioepithelial cells
E. Kuntz, U. Hoeller, B. Greatrix, C. Lankin, N. Seifert, S. Acharya, G. Riss, P. Buchwald-Hunziker,
W. Hunziker, R. Goralczyk, K. Wertz
5. Beta-carotene beadlets do not cause changes in RARbeta, RARalpha and PCNA
expression nor in histology in ferret lungs
A. Wyss, V. Elste, A. Kliemant, W. Cohn, U. Hoeller, F. Ringenbach, G. Riss, E. Wolz, D. Wolff,
J. Bausch, R. Goralczyk
6. Effects of oral beta-carotene supplementation on cell cycle markers in the lungs
of ferrets
M.A. Fuster, C. Picó, P. Oliver, J. Sánchez, A. Palou
7. Beta-carotene stability and uptake by human lung bronchial epithelial cells
depending on delivery vehicle
A.M. Rodriguez, S. Sastre, J. Ribot, A. Palou
8. Comparison of influence of beta-carotene on EPC and HUVEC
B. Kieæ-Wilk, A. Polus, J. Grzybowska, M. Miko³ajczyk, J. Hartwich, T. Langmann,
G. Schmitz, A. Dembiñska-Kieæ
9. Proangiogenic activity of beta-carotene is coupled with the activation
of endothelial cell chemotaxis
A. Polus, J. Grzybowska, M. Miko³ajczyk, B. Kieæ-Wilk, J. Hartwich, T. Langmann,
G. Schmitz, A. Dembiñska-Kieæ
10. Influence of squalene treatment on signal transduction
O. Bogdanova, L. Ostapchenko
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11. Influence of PPARg agonists on endothelial cells differentiation and on bFGF
and VEGF-dependent tubulogenesis
J. Grzybowska, B. Kieæ-Wilk, A. Polus, E. Pi¹tkowska, K. Kristiansen, A. Dembiñska-Kieæ
12. The effect of beta-carotene on differentiation, cytotoxicity, apoptosis and
proliferative potential on the three human acute leukemia cell lines
T. Sacha, M. Zawada, J. Hartwich, Z. Lach, A. Polus, M. Szostek, E. Zdzi³owska,
M. Libura, M. Bodzioch, A. Dembiñska-Kieæ, R. Goralczyk, K. Wertz, G. Riss,
C. Moehle, T. Langmann, G. Schmitz, A.B. Skotnicki
13. The potential of beta-carotene to influence the cell fate through the induction
or inhibition of apoptosis
M. Bodzioch, A. Dembiñska-Kieæ, J. Hartwich, K. £apicka-Bodzioch, J. Grzybowska,
A. Polus, I. Wybrañska, A. Banaœ, J. Duliñska, D. Gil, P. Laidler, W. Placha, M. Zawada,
A. Balana-Nowak, T. Sacha, B. Kieæ-Wilk, A.B. Skotnicki, C. Moehle, T. Langmann, G. Schmitz
14. Effect of catechin and epicatechin on pyruvate dehydrogenase kinase
activity in primary culture of rats hepatocytes
M. Tyszka-Czochara, M. Knapik-Czajka, A. GoŸdzialska, J. Jaœkiewicz
15. Effect of polyphenols and etanol on pyruvate dehydrogenase kinase activity
in primary culture of rats hepatocytes
M. Tyszka-Czochara, M. Knapik-Czajka, A. GoŸdzialska, J. Jaœkiewicz
II. Adipocytes
1. UCP1 is expressed in both white and brown adipose tissues of ferrets
and is down-regulated after six month daily oral beta-carotene supplementation
J. Sánchez, M.A. Fuster, P. Oliver, C. Picó, A. Palou
2. Modulation of resistin expression by retinoic acid and vitamin A status
F. Felipe, J. Ribot, M.L. Bonet, A. Palou
3. Retinoic acid treatment induces brown fat cell features in murine white
adipose tissues
J. Mercader, F. Felipe, J. Ribot, A. Palou, M.L. Bonet
4. Effect of PPAR gamma agonist and high fat diet on the content and composition
of ceramides and sphingomielines in the skeletal muscle of the rat
M. ¯endzian-Piotrowska, P. Zabielski, M. Baranowski, J. Górski
5. The adiponectin level in patients with familial obesity
Ma³gorzata Malczewska-Malec (Poland)
6. The quest for metabolic syndrome in the nutrigenetics era: beta adrenergic
gene polymorphisms and weight lowering therapies
Magdalena Szopa (Poland)
III. Beta-carotene uptake-metabolism
1. SNPs as determinants of inter-individual variation in beta-carotene/vitamin A
metabolism
W. Leung, C. Meplan, J. Hesketh, G. Lietz
2. Switching between physical and chemical mechanism of ROS quenching
by carotenoids
J. Fiedor, R. Haessner, H. Scheer, L. Fiedor
3. Generation and phenotyping of the beta-carotene 15,15’-monooxygenase
KO mouse
A. Eichinger, R. Goralczyk, A. Wyss
4. Lutein, zeaxanthin and lipids as risk and protection factors of age-related
macular degeneration
M. Drobek-S³owik, K. Safranow, K. Jakubowska, M. Raæ, D. Karczewicz, D. Chlubek
5. Susceptibility of lipids from different flax cultivars to peroxidation and its
lowering by added antioxidants
A. Krasowska, J. Szopa, M. Lukaszewicz
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6. Differences in all-trans beta-carotene (BC) uptake and eccentric cleavage
by human endothelial and neoplastic cell lines
J. Hartwich, J. Zagajewski, A. Polus, J. Duliñska, T. Sacha, G. Riss, J. Grzybowska,
M. Miko³ajczyk, P. Laidler, I. Wybrañska, R. Goralczyk, A. B. Skotnicki, A. Dembiñska-Kieæ
7. Effects of dietary lycopene on lipid parameters and yolk coloration in Japanese
quail
L. Bárdos, K. Réthy, Z. Kiss, C. Szabó
8. Beta-carotene and cigarette smoke: a chemical and biological approach
K. Vlismas, F.C.R. Manning, G.M. Lowe
9. Chemical composition of dried biomass of Blakeslea trispora
E. Kunschikova, V. Narushin, I. Kunschikova, A. Tyurenkov
10. Profiles of lipids in fruit-bodies of some edible mushrooms
K. Grzywnowicz
14:00 –15:00 L u n c h  b r e a k  (Zodiak Hall, Œw. Anny 12 Str.)
SESSION III
CAROTENOIDS — THE BIOPHYSICAL ASPECTS
Chairmen: Wilhelm Stahl, Kazimierz Strza³ka
15:00 Introduction
Kazimierz Strza³ka (Poland)
15:05 Carotenoids in nutritional protection
Wilhelm Stahl (Germany)
15:35 Are lycopene and other dietary carotenoids beneficial? Reactions of carotenoids
with oxy-radicals and singlet oxygen
T. George Truscott (United Kingdom)
16:05 Carotenoids as modulators of lipid membrane physical properties
Wies³aw Gruszecki, Kazimierz Strza³ka (Poland)
16:35 Model and cellular in vitro study of antioxidant and photoprotective properties
of macular pigments
Tadeusz Sarna (Poland)
Sunday, 12 December 2004
C O L L E G I U M  N O V U M  ( A U L A )
THE COMMON SESSION OF ”DLARFID”
DIETARY CAROTENOIDS AND LIPIDS: LESSON LEARNED FROM EPIDEMIOLOGICAL
AND GENETIC STUDIES
And
COST B17 ACTION WORKING GROUP 1:
GENETIC ASPECTS OF NIDDM, OBESITY, INSULIN RESISTANCE AND AGEING
Chairmen: Bela Bendlova, Aldona Dembiñska-Kieæ
8.15 Welcome to participants
Aldona Dembiñska-Kieæ
8:30 Roles of PPAR delta in lipid absorption and metabolism. A new target for the treatment
of type 2 diabetes
Paul A. Grimaldi (France)
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9:00 A novel method for rapid quantification of free and esterified phytosterols in serum
using APPI tandem mass spectrometry
Joachim Thiery (Germany)
9:30 Synergistic effects of zeaxanthin and its binding protein in the prevention of lipid
membrane oxidation
Prakash B. Bhosale (United States of America)
10:00 Induction of PXR-mediated metabolism by b-carotene
Ralph Rühl (Hungary/Germany)
10.30 Association of adipose and red blood cell lipids with severity of dominant
Stargardt macular dystrophy
Paul S. Bernstein (United States of America)
11.00 The risk polymorphisms of UCP1 and PPARG2 genes in patients with polycystic
ovary syndrome
Bela Bendlova (Czech Republic)
11.30–12.15 SHORT PRESENTATIONS
Insulin resistance and the beta cell function in relation to selected DM2 candidate
genes
Marketa Vankova (Czech Republic)
The KCNJ11 gene polymorphism E23K in relation to DM2 in Czech population
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Fatty acid composition of fats
as an early determinant
of childhood obesity
G. Ailhaud, P. Guesnet
Centre Biochemie UMR6543CNRS, Faculty of Sciences, Nice,
France
High-fat diet is known to be associated with fat mass gain.
However, there is a lack of a general increase in energy intake
as fat among youths despite a striking increase in the prevalen-
ce of overweight and obesity in industrial and developing co-
untries.  Decreased physical activity and nonexercise activity
thermogenesis have been implicated to explain this paradox.
Long-term relationship between fatty acid composition of in-
gested fats and the development of adipose tissue in infants is
difficult to assess in contrast to animals.  In vitro, among natural
long-chain fatty acids, dihomo-gamma-linolenic acid (20:3,
omega-6) and arachidonic acid (C20:4, omega-6), metabolites
of essential linoleic acid (C18:2, omega-6), promote substan-
tially adipogenesis of preadipocytes.  Arachidonic acid acts thro-
ugh the prostacyclin signalling pathway which involves the cell
surface prostacyclin receptor IP-R. In contrast, eicosapentae-
noic acid (EPA) and docosahexaenoic acid (DHA), metabolites
of essential alpha-linolenic acid (C18:3, omega-3), are anti-adi-
pogenic and counteract the effect of arachidonic acid.  In vivo,
under isoenergetic conditions, nutritional experiments with li-
noleic acid-enriched diet and with linoleic acid/a-linolenic acid-
enriched diet in wild-type and IP-R K.O. mice show the impor-
tance of the arachidonic acid/prostacyclin pathway in enhan-
cing adipose tissue development during the gestation/suckling
period.  Published U.S. data show over the last decades a dra-
matic and specific increase in the amount of linoleic acid but
not in that of alpha-linolenic acid consumed by infants fed
breast-milk or formula-milk.  Thus it is proposed that the fatty
acid composition of ingested fats is an early determinant  of
childhood obesity, i.e. at a time where adipose tissue exhibits
a very dynamic phase of its development.
Challenges to understanding and
measuring carotenoid bioavailability
S. Southon, R. Faulks
Institute of Food Research, Norwich Research Park, Colney,
Norwich, United Kingdom
Carotenoids are an excellent example of where too little
understanding of food structure, the complexity of their beha-
viour during digestion, and the cause of inter-individual respon-
se, can lead to misinterpretation of study results. This may lead
to confusion in understanding their relevance to health. It is
essential that all those utilising the output from bioavailability
studies are conversant with the challenges in measuring caro-
tenoid bioavailability, to ensure that model systems for the in-
vestigation of functional response are realistic and dietary stra-
tegies are soundly based.
The presentation outlines four challenges associated with
understanding and measuring carotenoid bioavailability. These are
(i) release of carotenoids from the food structure and processing
into a potentially absorbable form (bioaccessibility), (ii) passage
of carotenoids from gut lumen into the body (absorption),
(iii) interpreting plasma response and (iv) inter-individual variation.
In summary, the bioaccessibility of carotenoids is gover-
ned by the physical properties of the food matrix, which
affects the efficiency of the physical, enzymic and chemical di-
gestion processes.
Carotenoids used as colorants are likely to be relatively
better absorbed, because of the form in which they are dis-
persed in food. The extent of absorption of carotenoid supple-
ments will depend on the size of the dose and proximity of
dosing to the consumption of a fat containing meal. The re-
lease of carotenoids from food plants occurs only when the
plant cell is fractured and this occurs only during food prepara-
tion, processing and/or mastication, not during digestion.
Following release from the food matrix the major limiting
factor governing the extent of absorption is the solubility in
digesta. Carotenoid solubility is a major challenge in the design
of cell culture studies. The use of non-physiological carotenoid
delivery systems, and the poor understanding of their effect
on cell response, is a matter of concern regarding conclusions
drawn from cell studies.
Absorption studies are best carried out by measuring the
chylomicron carotenoid excursion and modelling this with some
measure of chylomicron turnover rate (t1/2). In this way inter-
individual differences in lipoprotein metabolism can, in part,
be taken into account before formulating conclusions on the
rate and extent of carotenoid absorption.
Fatty acids and expression
of adipokines
C.A. Drevon
Department of Nutrition, Institute of Basic Medical Sciences,
University of Oslo, Norway
Adipose tissue has been recognised as the quantitatively
most important energy store of the human body for many years,
in addition to its functions as mechanical and thermic insulator.
In mammals, the adipose organ is localised in several depots
including white as well as brown adipose tissues. The largest
depots are found subcutaneously and in the abdominal region.
ORAL PRESENTATIONS
22
Acta Angiol., 2004, Vol. 10, Suppl, Abstracts
www.angiologia.pl
Several secretory proteins are synthesised in adipose tis-
sue including leptin, resistin, adiponectin, tumor necrosis fac-
tor (TNFa), angiotensinogen, adipsin, acylation-stimulating pro-
tein, retinol-binding protein (RBP), interleukin (IL)-1beta, IL-6,
IL-8, IL-10, plasminogen activator inhibitor-1 (PAI-1), fasting-
induced adipose factor, fibrinogen-angiopoietin-related prote-
in, metallothionein, tissue factor (TF), complement C3, fibro-
nectin,  haptoglobin, entactin/nidogen, collagen VI a 3, pigment
epithelium-derived factor (PEDF), hippocampal cholinergic
neurostimulating peptide (HCNP), neutrophil gelatinase-asso-
ciated lipocalin (NGAL) and adiponutrin.
Fatty acids may influence the expression of adipokines like
leptin, resistin or adiponectin directly by interaction with trans-
cription factors, or indirectly via unknown mechanisms possi-
bly linked to fatty acid oxidation, synthesis or storage. Because
fatty acids are the main components of adipose tissue it is
of essential interest to clarify the biological effects of different
types of fatty acids on the expression of relevant adipokines.
Structurally different marine
oils in health and medicine
T. Bjørkkjær1, K. Gregersen1, A. Røyneberg1,
G. Arslan1, 2, l.A. Brunborg1, A. Berstad2, L. Frøyland1
1National Institute of Nutrition and Seafood Research, Bergen,
Norway, 2Division of Gastroenterology, Institute
of Medicine, Haukeland University Hospital, Bergen, Norway
Most of the dietary TAGs are derived from vegetable oils,
particularly soybean oil which is very rich in linoleic acid (18:2n-6,
LA), which is the precursor of arachidonic acid (20:4n-6, AA).
Some vegetable oils like linseed oil and rapeseed oil contain
substantial amounts of a-linolenic acid (18:3n-3, ALA). Howe-
ver, the in vivo conversion of ALA to eicosapentaenoic acid
(20:5n-3, EPA) and particularly to docosahexaenoic acid (22:6n-3,
DHA) is limited in humans (Vermunth et al. 2000; Pawlosky
et al. 2001; de Groot et al. 2004). Thus, the high ratio of n-6/n-3
fatty acids of the Western diet leads to a high ratio of 20:4 n-6/
/20:5n-3 in the blood and tissues. 20:4n-6 in cell membrane
phospholipids is the substrate for the synthesis of a range of
biologically active eicosanoids. The current Western diet (fat)
may therefore promote IBD and other chronic inflammatory
diseases like rheumatic disorders by facilitating the production
of pro-inflammatory eicosanoids (Gil 2002; Simopoulos 2002).
In addition, lipids used in nutritional support of surgical and
critically ill patients have been based on soybean oil leading to
an increase in the total amount of n-6 fatty acids in cell mem-
branes. There is a view that an excess of n-6 fatty acids should
be avoided since this contributes to a state where physiologi-
cal processes may become dysregulated (Arslan et al. 2002;
Gil 2002; Simopoulos 2002; Calder 2003). All patients com-
pleted treatment with seal oil without relevant protocol viola-
tions. No relevant subjective side effects of the seal oil admini-
stration were detected. Compared to control subjects, a lo-
wer n-3/n-6 ratio was found in rectum biopsies from patients
with IBD, but this was normalised after seal oil treatment
(Figure 1). Total amount of n-6 fatty acids in serum was signifi-
cantly reduced (p = 0.016) whereas a significant increase
(p = 0.01) in n-3 fatty acids (20:5n-3, p = 0.002 & 22:6n-3,
p = 0.04) was observed. The total amount of saturated and
monounsaturated fatty acids in serum were not changed after
seal oil administration. The ratio of n-6 to n-3 in serum was
significantly lowered (p < 0.0001) by seal oil treatment.
Figure 1. n-3/n-6 ratio in control rectum biopsies (n = 20)
compared to rectum biopsies from patients with IBD (n = 9)
at baseline and after ten days of treatment with seal oil
This study demonstrates that seal oil treatment significan-
tly increases the amount of n-3 PUFAs in serum and rectum
biopsies from patients with IBD with a concomitant pain relief.
These results are in accordance with a previous pilot study
using a short term (ten days) duodenal seal oil treatment to
patients with IBD (Arslan et al. 2002). In conclusion, seal oil
administration seems to improve the fatty acid profile of the
rectum epithelium and possess a pain relieving effect in pa-
tients with IBD. Seal oil may prove to become an alternative
for nutraceutical as well as additional treatment of IBD and it
seems as seal oil represent valuable tool to further study the
absorption and clearance of lipids.
Arslan G, Brunborg LA, Frøyland L, Brun JG, Valen M, Berstad A
(2002) Lipids 37, 935–940.
Calder PC (2003) Braz J Med Biol Res 36, 433–446.
Gil Á (2002) Biomed Pharmacother 56,388-396.
de Groot RH, Hornstra G, van Houwelingen AC Roumen
F (2004) Am J Clin Nutr 79, 251–260.
Pawlosky RJ, Hibbeln JR, Novotny JA & Salem Jr N (2001)
J Lipid Res 42,1257–1265.
Simopoulos AP (2002) J Am Coll Nutr 21, 495–505.
Vermunt SHF, Mensink RP, Simonis MMG, Hornstra G (2000)
Lipids 35, 137–142.
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Mechanisms of genomic and
non-genomic actions of carotenoids
R. Elliott
Institute of food Research, Norwich Research Park, Colney,
Norwich, United Kingdom
Carotenoids are bioactive dietary compounds that may be
able to influence human health. A large proportion of the re-
search to date has focused on the potential role of the caro-
tenoids as dietary antioxidants. However, the true significance
of these effects both under normal physiological conditions and
conditions of oxidative stress remains unclear. Other mecha-
nisms of action that are independent of their antioxidant pro-
perties may be as, or even more, important. One obvious exam-
ple is that certain members of the carotenoid family can be
processed within the body to yield vitamin A, a potent bioacti-
ve agent exerting profound effects on processes such as tissue
development and disease prevention. But by no means all the
observed effects of carotenoids can be explained simply on
the basis of pro-vitamin A activity. Overall there is still a consi-
derable degree of uncertainty about the actual mechanisms
underlying of various biological effects of carotenoids. The de-
velopment of functional genomic techniques provides resear-
chers with powerful new approaches that can be used to start
to elucidate the relative contributions different mechanisms.
However, there are still technical challenges to address. In stu-
dies involving human volunteers, the key tissues of interest often
are not obtainable in sufficient quantity at serial sampling
points or simply not available at all. This makes the use of model
systems necessary. If animal models are to be used, very care-
ful selection of the most appropriate model is essential. Hu-
man cell culture systems have the advantages of simplicity and
the ability to achieve close experimental control. However,
most cell culture systems use immortalised or cancer cells that
may not always respond in a manner fully representative of
normal cells in vivo. Furthermore efficient and representative
delivery of the lipophilic carotenoids to cell in culture presents
a particular technical challenge. Very careful attention to detail
in the design experiments is vital to unravel this complex story.
Towards a better understanding
of carotenoid metabolism in animals
J. von Lintig, S. Hessel, A. Isken, C. Kiefer,
J.M. Lampert, O. Voolstra, K. Vogt
Institute of Biology I, Department of Animal Physiology and
Neurobiology, University of Freiburg, Freiburg, Germany
Animals, in general, cannot synthesize vitamin A de novo,
but rely on a supply of dietary precursors. All naturally occur-
ring vitamin A derives by enzymatic oxidative cleavage from
carotenoids with provitamin A activity. This process follows
a universal scheme in animals. To become biologically active,
carotenoids must first be absorbed, then delivered to the site
of action in the body, and in the case of the provitamin A func-
tion, metabolically converted. In the fruit fly Drosophila — with
vitamin A functions being restricted to the visual system
— blind mutants with impairments in this pathway have been
isolated. The eye phenotype of ninaD flies is characterized by
an absence of both carotenoids and retinoids, while in ninaB
flies only retinoids are missing and carotenoids are highly accu-
mulated. Our analyses revealed that the ninaD gene encodes
a cell surface receptor rendering carotenoids available cellu-
larly. NinaB, a beta, beta-carotene-15,15’-oxygenase, cataly-
zes the oxidative cleavage of the provitamin A, the key step in
vitamin A formation, to give two molecules of retinal. By sear-
ching for similar genome sequences in vertebrates, we identi-
fied three ninaB homologous genes. By loss-of-function expe-
riments, we addressed their roles in vitamin A metabolism
during zebrafish development. These analyses revealed that
we identified a novel class of carotenoid/retinoid metabolizing
enzymes with essential functions in retinoic acid signaling as
well as in vision.
1. Kiefer C, Sumser E, Wernet MF, Lintig J. (2002) Proc Natl Acad
Sci USA 99: 10581–10586.
2. von Lintig J, Dreher A, Kiefer C, Wernet MF, Vogt K. (2001)
Proc Natl Acad Sci USA 98: 1130–1135.
3. Kiefer C, Hessel S, Lampert J, Vogt K, Lederer MO, Breithaupt,
DE, von Lintig J (2001) J Biol Chem 276: 14110–14116.
4. Lampert JM, Holzschuh J, Hessel S, Driever W, Vogt K, von Lintig J.
(2003) Development 130: 2173–2186.
Morphology of ferret subcutaneous
adipose tissue after six-month daily
supplementation with oral beta-
-carotene
S. Cinti, M. Morroni
University of Ancona, Ancona, Italy
Adipose tissue is an important retinoid depot and retino-
ids are known to influence white and brown adipocyte meta-
bolism. Identifying nutrients that can affect the biological acti-
vity of the adipose organ would be of great medical interest in
the light of the current obesity epidemic and related disorders
in developed countries. The vast majority of mammal studies
of chronic administration of oral beta-carotene have used mu-
rine models, while few have employed mammals exhibiting
uptake and processing of intestinal beta-carotene similar to
those of humans. While rodents transform practically all inge-
sted beta-carotene into retinol, in ferrets, as in humans, part of
the beta-carotene is absorbed and released into the circula-
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tion intact. We studied the effects of 6-month daily administra-
tion of two doses of oral beta-carotene (0.8 mg/kg/day or
3.2 mg//kg/day) on ferret body weight, size of body fat depots,
and, using morphological and morphometric methods, on sub-
cutaneous (inguinal) white adipose tissue (WAT). Because
of the oral mode of administration, liver, stomach, and small and
large intestine were also studied. Control animals received the
vehicle. Data show that at the end of treatment the higher
dose induced significantly higher body weight compared with
controls and significantly higher inguinal fat depot compared
with animals treated with the lower dose. In addition, chronic
treatment with beta-carotene induced a dose-dependent hy-
pertrophy of white adipocytes and increased neoangiogenesis in
subcutaneous WAT in all treated ferrets. Vasculogenesis was in-
dependent of adipocyte hypertrophy. We also found focally evi-
dent liver steatosis in the ferrets treated with the higher dose of
beta-carotene. The other gastrointestinal tract organs studied were
not significantly different from those of control animals.
Gene regulation by beta-carotene
in ferrets
A. Palou, C. Picó
Laboratorio de Biología Molecular, Nutrición y Biotecnología,
Departamento de Biología Fundamental y Ciencias de la Salud,
Universitat de les Illes Balears, Palma de Mallorca, Spain
The ferret have been proposed as useful model to study
human beta-carotene absorption and cleavage as these animals
also absorb and release intact beta-carotene from the entero-
cyte. One of the interest for the study of beta-carotene effects
on these animals come from epidemiological studies showing
that people that eat more fruits and vegetables (which are rich
in carotenoids) and people having higher serum beta-carotene
levels have a lower risk of cancer, particularly lung cancer.
However, the two main human intervention studies using
moderate daily doses of beta-carotene supplementation
(20 mg in the ATBC trial; 30 mg in CARET trial) revealed an
increased risk of lung cancer among smokers and asbestos wor-
kers. The knowledge on beta-carotene metabolism in both
humans and ferrets is scarce and the vast majority of studies
on mammalian beta-carotene have used rodents or other la-
boratory small mammals, this species not absorbing beta-ca-
rotene as such care.
Previous studies carried out in the ferret have reported
that the administration of a pharmacological dose (2.4 mg/kg
body weight/day) of beta-carotene (SIGMA) lead to squamous
metaplasia and increases the expression of some proto-onco-
genes. Conversely, a physiological dose of beta-carotene
(0.43 mg/kg body weight/day) did not show these effects, but
even provided mild protection again squamous metaplasia in
smoke-exposed ferrets. We treated ferrets with two oral do-
ses (0.8 and 3.2 mg/kg body weight/day) of beta-carotene for
6 months; beta-carotene used was supplied from DSM Nutri-
tional Products Ltd. as a water soluble formulation (beadlets)
containing 0.1% beta-carotene crystalline, 0.015% DL-alpha-
tocopherol, 0.04% ascorbyl palmitate, 0.04% corn oil, 0.15%
fish gelatine, 0.34% sucrose and 0.315% corn starch. We did
not find apparently detrimental effects of beta-carotene on lung
cell proliferation. These seemingly paradoxical results suggest
that, in addition to the dose, the formulation (e.g. the presen-
ce of alpha-tocopherol or other antioxidant compounds) may
be important in determining the pro- or anti-carcinogenic
effects of beta-carotene.
We also found that ferrets treated with the high dose
of beta-carotene gained more weight than control animals and
had a higher size of the inguinal subcutaneous fat depot. More
studies are being carried out to elucidate the mechanistic basis
for these observations.
Gene expression profiling identifies
retinoids as potent inducers of
macrophage lipid efflux
T. Langmann, G. Liebisch, C. Moehle,
R. Schifferer, M. Grandl, G. Schmitz
Institute of Clinical Chemistry, University of Regensburg,
Germany
Vitamin A and its naturally occuring derivatives 9-cis reti-
noic acid (9-cis RA) and all-trans retinoic acid (ATRA) exert
a variety of biological effects including immunomodulation,
growth, differentiation, and apoptosis of normal and neobla-
stic cells. In order to directly study the effects of these reti-
noids on macrophage gene expression and lipid metabolism, pri-
mary human monocytes and in-vitro differentiated macropha-
ges were stimulated with b-carotene, 9-cis RA, and ATRA and
global gene expression profiles were analyzed by Affymetrix
DNA-microarrays and differentially regulated genes were ve-
rified by quantitative TaqMan RT-PCR. Among others, we have
identified a strong upregulation of a cluster of genes involved
in cholesterol metabolism including apolipoproteins (apoC-I,
apoC-II, apoC-IV, apoE), the scavenger receptor CD36, ste-
roid-27-hydroxylase (CYP27A1), liver-X-receptor a (LXRa),
and ATP-binding cassette transporters A1 (ABCA1) and G1
(ABCG1). The induction of these genes could be also confir-
med in the human THP-1 monocytic cell model. Interestingly,
the induction of these genes was most effective with 9-cis RA
and was independent of monocytic differentiation and lipid lo-
ading. Since the CYP27A1 gene displayed the strongest upre-
gulation on the mRNA level, we cloned various deletion con-
tructs of the promoter region and analyzed the response to
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retinoids in macrophages. Thereby, a novel retinoid acid-res-
ponsive element could be located within 191bp of the proxi-
mal CYP27A1 promoter. To further assess the functional con-
sequences of retinoid receptor action, we carried out pho-
spholipid and cholesterol efflux assays in stimulated macropha-
ges. A strong induction of apoA-I-dependent lipid efflux, wi-
thout prior loading of cells with modified lipoprotein-derived
or free cholesterol could be observed. This clearly implies that
the strong positive effects of retinoids on the expression of
key genes in macrophage cholesterol metabolism equally trans-
lates into biological functions reflected by a strong increase in
specific lipid efflux.
Vitamin A as a regulator
of adipogenesis and adipocyte
metabolism-derived medical
complications
M.L. Bonet, A. Palou
Laboratory of Molecular Biology, Nutrition and Biotechnology,
Universitat de les Illes Balears, Palma de Mallorca, Spain
Beyond their classical nutritional value, nutrients affect many
fundamental biological processes through modification of gene
expression and function.  An emerging example is the involve-
ment of vitamin A in the control of biological aspects regula-
ting the level and functioning of body fat reserves.
Retinoic acid (RA), the carboxylic acid form of vitamin A,
influences adipocyte differentiation and survival, with high doses
inhibiting and low doses promoting adipogenesis of preadipose
cells in culture.  In addition, RA signals transcriptional activation
of the genes encoding uncoupling proteins (UCPs), which are
mitochondrial proteins involved in energy dissipation and fatty
acid metabolism.  In rodents, acute administration of RA results
in reduced body weight and adiposity in the absence of changes
of food intake, increased thermogenic capacity in brown adipo-
se tissue and muscle, reduced adipogenic and lipogenic capacity
in adipose tissues, and appearance of metabolic features of brown
adipocytes (which are cells specialized in inefficient fuel oxida-
tion) in white adipose tissue depots.  Chronic dietary vitamin A
supplementation also increases thermogenic potential of brown
fat and muscle, and appears to confer some resistance to high-
fat diet induced obesity in rodents.  A poor vitamin A status, on
the other hand, favors in rodents an increment of adiposity and
there are some studies linking a low dietary intake of vitamin A
with a high incidence of obesity in human populations.  RA also
has important, direct effects on the expression of adipocyte-
derived protein signals involved in the control of energy balan-
ce, adipose tissue development and insulin sensitivity, such as
leptin and resistin, inhibiting the expression of both.
Knowledge of the impact of vitamin A derivatives in
the regulation of adiposity, insulin sensitivity and energy expen-
diture may serve to define new directions for the development
of nutritional and pharmacological strategies to efficiently com-
bat obesity and type II diabetes, two closely related metabolic
diseases with an increasing and alarming incidence worldwide.
Transgenic embryonic stem cells
for basic research and clinical
application
J. Hescheler
Institut für Neurophysiologie, Köln, Germany
Because of their ability to reproduce the embryological
differentiation of nearly all different cellular phenotypes, em-
bryonic stem (ES) cells represent an ideal tool to to study pro-
cesses of embryogenesis under in vitro conditions, in particular
the signalling cascades and genes involved in the functional de-
velopment (functional genomics) as well as to provide a new
source for cellular replacement therapy. We have cultivated
ES cells in three dimensional cell aggregates, where they diffe-
rentiate into derivatives of all three germ layers.
1. Embryonic vascularization comprises different processes
such as proliferation, migration, differentiation and tube-forma-
tion of endothelial cells. To date little is known about morpho-
genetic changes of endothelial cells and the molecular mechani-
sms involved occurring during early stages of embryonic deve-
lopment. We have therefore established stably transfected mo-
use ES cell lines, where the endothelial-specific platelet endo-
thelial cell adhesion molecule (PECAM) promoter drives
the expression of the live reporter enhanced green fluorescent
protein (EGFP). This approach enables investigation of morpho-
genetic changes and related signalling cascades in endothelial cells
during early embryonic development. Morphogenetic changes
of endothelial cells in the presence of key regulatory molecules
fibroblast growth factor (FGF) and vascular endothelial growth
factor (VEGF) are monitored employing time lapse microscopy.
Three days post plating EGFP positive cells are detected in the
ES cell aggregates. At first, clusters of angioblasts are predomi-
nant which later develop into elongated network-like structu-
res. VEGF induces proliferation and pronounced sprouting
angioblasts whereas FGF leads to stabilization of preformed en-
dothelial structures. We conclude that the ES cell system in com-
bination with endothelial-specific EGFP expression is a valid tool
to investigate early events of vascular differentiation in vitro. VEGF
plays an important role for early vessel formation whereas FGF
is crucial for endothelial survival. Because of their ability to pro-
mote capillarization and angiogenesis ES cells may be usefull for
recapillarization after cardiac infarction.
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2. This potential is paralleled by their ability to generate
cardiomyocytes in vitro for tissue repair. Cardiomyocytes
differentiated from ES cells were injected into the cryoinfarcted
left ventricular wall of adult wild type mice. Immunological cross
reactions were avoided by using the same inbred mouse strain.
To allow identification of the transplanted cells transgenic ES
cells were used carrying an IRES vector with two cloning sites
for EGFP and an antibiotics resistance for selective selection
both under the a-MHC promoter. EGFP positive transplanted
cardiomyocytes could be easily detected in the native heart at
different intervals after operation. The cells were found to
engraft and differentiate into adult-like cardiomyocytes as con-
firmed by cross striation after immunostaining with
a-actinin. These data were corroborated by patch clamp expe-
riments on isolated EGFP positive cardiomyocytes at different
time points after operation. The transplanted cells displayed
ventricular action potentials and b-adrenergic — as well as mu-
scarinic regulation. When survival was investigated in a large
colony of transplanted- (n = 99) and control mice (n = 36) where
NaCl instead of transgenic cardiomyocytes were injected,
the control group had an almost double mortality rate. Our data
show engraftment and differentiation of embryonic cardiomy-
ocytes after transplantation into cryoinfarcted areas of heart.
3. Before a clinical use of human ES cells for therapeutic
trials in humans two major prerequisites must be fulfilled:
(i) they must be safe, i.e. the development of tumours because
of the high proliferative potential must be omitted and
(ii) the rejection of the transplanted cells must be prevented. For
the criterion (i) the technology of “lineage selection” has been
developed, strategies in order to only allow the needed cell to
differentiate from ES cells but all other cells are prevented to
survive. This can be obtained by modifying the culture condi-
tions and/or adding a combination of various growth factors
and signalling molecules  which preferentially supports
the growth of a specific cell type but prevents the develop-
ment of other types. However, up to now, the transgenic drug
selection approach has proven to be the  most specific and
effective for reliable purification of ES cell derived cells. For
example, IRES-vectors encoding EGFP and the puromycin re-
sistance gene under specific promoters are used. Application
of puromycin (optimal time point will be seen from the EGFP
expression) will eliminate all other cells except those conta-
ining the resistance gene. In our experiments using cardiac spe-
cific promoters we found an extremely efficient purification of
over 99%. For the criterion (ii) several suggestions have been
made: the most simple one is of course the development of a
stem cell bank containing 1000 or more ES cell lines with diffe-
rent immunological determinants (MHC surface complexes,
HLA system). Alternatively it is suggested to use the so called
“therapeutic cloning”, i.e. the exchange of the haploid nucleus
of a donor oocyte by that of the patient. It has been demonstra-
ted that the oocyte with the new nucleus develops to a normal
blastocyst from where a new patient identical ES cell line can
be prepared from the inner cell mass. In order to prevent
the high number of donor oocytes it may be also possible to
directly differentiate oocytes from ES cells.
PPARg in the control of brown
adipocyte differentiation
J. Nedergaard, N. Petrovic, E.M. Lindgren,
A. Jacobsson, B. Cannon
The Wenner-Gren Institute, The Arrhenius Laboratories F3,
Stockholm University, Stockholm, Sweden
The effects of fatty acids and retinoic acid (carotene) on
brown adipose tissue differentiation are mediated by the trans-
cription factors PPARg and PPARa in combination with RXR.
There is good support for the idea that stimulated PPARg pro-
motes adipogenesis also in brown adipose tissue. However,
the issue is more complex concerning the full differentiation to
the brown adipocyte phenotype, particularly the expression
of the brown-fat-specific marker UCP1. The effect of norepi-
nephrine on PPARg gene expression, at least in-vitro, is negati-
ve, PPARg-ablated brown adipose tissue can express UCP1,
and PGC1-a may coactivate other transcription factors (inclu-
ding PPARa); thus, the significance of PPARg for the physiolo-
gical control of UCP1 gene expression is not settled. Howe-
ver, importantly, the effects of PPARg agonists demonstrate
the existence of a pathway for brown adipose tissue recruit-
ment that is not dependent on chronic adrenergic stimulation
and may be active in recruitment conditions such as prenatal
and prehibernation recruitment. The ability of chronic PPARg
agonist treatment to promote the occurrence of brown-fat-
features in white adipose tissue-like depots implies a role in
anti-obesity treatment, but this will only be effective if the extra
thermogenic capacity is activated by adrenergic stimulation.
Regulation of adipocyte
differentiation and function
by polyunsaturated fatty acids
L. Madsen, R. Koefoed Petersen, K. Kristiansen
Department of Biochemistry, Molecular Biology, University
of Southern Denmark, Odense, Denmark
A diet enriched in PUFAs, in particular of the n-3 family,
decreases adipose tissue mass and suppresses development of
obesity in rodents. Although several nuclear hormone recep-
tors are identified as PUFAtargets, the precise underlying me-
chanism behind this effect is still not elucidated. Here we re-
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view research aimed at elucidating molecular mechanisms go-
verning the effects of PUFAs on differentiation and function of
white fat cells with special emphasis on dietary PUFAs as sig-
naling molecules.
Molecular mechanisms controlling
white versus brown adipocyte
differentiation
K. Kristiansen
Department of Biochemistry and Molecular Biology University
of Southern Denmark, Odense, Denmark
In response to cues that still remain enigmatic, mesenchy-
mal stem cells give rise to adipocyte precursor cells, which
subsequently differentiate into one of two major cell popula-
tions with different physiological roles, white and brown adi-
pocytes. Two major regulators of the mammalian cell cycle,
the retinoblastoma protein (pRB) and p53 have been implica-
ted in the control of adipocyte differentiation. Initially, it was
reported that pRB was required for adipocyte differentiation,
whereas circumstantial evidence linked p53-deficiency to
brown adipocyte differentiation. We have now demonstrated
that the situation is much more complex in that pRB promotes
differentiation of white adipocytes, but inhibits the formation
of brown adipocytes. In contrast, p53 appears to be a general
inhibitor af adipocyte differentiation, and down-regulation of
p53 expression seems to be an integral part of the differentia-
tion program leading to either white or brown adipocytes.
Umbilical cord progenitor cell
differentiation in the presence
of PPAR-gamma and RAR/RXR
activators
A. Dembińska-Kieć1, A. Polus, J. Grzybowska1,
T. Langmann3, G. Schmitz3, M. Ratajczak2
1Department of Clinical Biochemistry, 2Department
of Transplantology, The Jagiellonian University Medical College,
Kraków, Poland, 3Department of Clinical Chemistry and
Laboratory Medicine University of Regensburg, Regensburg,
Germany
Peroxisome proliferation-activated receptor gamma
(PPAR-gamma) stimulated by fatty acids, its derivates as well
as exogenous compounds (e.g. glitazones)  heterodimerizing
with the carotenoid/retinoid-activated RAR/RXR transcription
factors are important regulators of cell fate. Progenitor stem
cells persist in adult life, and contribute in the tissue repair such
as in neovasculogenesis. Markers of circulating early endothe-
lial progenitors cells (EPC) are (in between): CD34, AC133,
PECAM-1/CD31, VE-cadherin and flk1 (VEGF-R2). Such cells
leaving bone marrow are under influence of circulating in
blood  lipoproteins with their lipids and lipid-soluble compo-
unds including retinoids.
Aim of the study was to analyze the human endothelial
(HUVEC) and umbilical cord (UPC) differentiation under in-
fluence of lipoprotein  PPAR/RAR/(RXR) activators
Material and methods: CD34/AC133 were isolated from
human cord blood using magnetic microbits (Milteny Biotech).
Primary cultures of HUVEC were isolated from human umbi-
lical vein using collagenase digestion method. Cells were grown
in EBM medium with supplement and antibiotics. Influence
of PPARs activators (palmitic, linoleic , arachidonic acids,  lyso-
phosphatidilcholine (oxPAPC, SPP-1) or b-carotene on the gene
expression after 24 hour incubation was estimated by real-time
PCR (Opticon) or by oligonucleotide chips (Affymetrix) analysis.
The changes in certain protein synthesis was proved by flow-
-cytometry. To determine the effect of factors on cell prolifera-
tion, the rate of DNA synthesis was estimated by measuring
BrdU incorporation. Influence of above compounds on first step
of angiogenesis — the tube formation was investigated  in the
3D in vitro Matrigel model assay.  Stromal Derived Factor (SDF)
or VEGF- induced chemotaxis was performed  and measured
by using BD Falcon Fluoro Bloc System (Becton Dickinson).
Results: On the contrary to VEGF, bFGF or leptin, the
PPAR-g activators  and b-carotene in non-toxic concentrations
did not significantly influence the proliferation and the tube
formation in the tubulogenesis model in vitro. In spite of not
significant influence of modified lipoproteins (ox LDL, oxPAPC)
on HUVEC or  EPC migration,  the VEGF or SDF-induced che-
motaxis was  significantly modified.  b-carotene alone stimula-
ted chemotaxis of the EPC. Microarray and real-time PCR ana-
lysis indicated that beta-carotene activated the gene expre-
ssion connected with cell differentiation, cell cycle, adhesion,
cell-cell signalling  chemotaxis, apoptosis as well as with induc-
tion of cyt P450 pathway of xenobiotic catabolism. The expre-
ssion of the EGF-1 transcription factor seems to play important
role  as the common regulator of above processes.
Conclussion: Our results confirm the influence of circula-
ting  lipoprotein PPAR/RAR/RXR agonists on the priming of
progenitor cells in early, invasive stages of new vessels forma-
tion what may by the undesirable side-effect of the  supportive
therapy with bone marrow progenitors such as neovasculoge-
nesis associating  atherosclerosis or diabetic retinopathy.
Supported by the EU F5 DLARFID QLTR-2001-00183 and
Polish State Research Grant No CR 90/2003, 501/KL/438/L. The
authors thank the DSM Nutritional Products for support.
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Effects of b-carotene and lycopene
in cells exposed to cigarette smoke
condensate: modulation of redox
sensitive molecular pathways
involved in cell growth
P. Palozza, S. Serini, G. Calviello
Institute of General Pathology, Catholic University, Rome, Italy
Human intervention trials suggested that b-carotene su-
pplementation results in an increased lung cancer incidence in
smokers, but not in non smokers. Since it is known that ciga-
rette smoke contains a large amount of free radicals and that
its metabolism further contributes to their formation, we stu-
died the relationship existing between cell growth and redox
status in Mv1Lu lung, MCF-7 mammary, DU145 prostate and
LS-174 colon cancer cells and immortalized RAT-1 fibroblasts
cells exposed to cigarette smoke condensate (tar) and b-caro-
tene or lycopene. We found that the association of tar and
b-carotene was able to: 1) increase cell number and the percen-
tage of cells in the S-phase through an increase of cyclin D1
and a decrease in the levels of p53 and p21 with respect to tar
alone; 2) inhibit apoptosis through changes in Bax protein;
3) exacerbate DNA oxidative damage, measured as 8-OHdG
formation; 4) increase the expression of Cox-2, a protein in-
volved in the production of reactive oxygen species and a sui-
table marker of smoke-related carcinogenesis; 5) modulate the
expression of some redox-sensitive enzymes, such as heme
oxygenase-1 (and its repressor gene Bach1), NADPH quinone
oxidoreductase, cytochrome P450 reductase. Such effects were
found at low concentrations of the carotenoid, ranging from
0.75 to 4.0 mM, and were not observed when cells were expo-
sed to b-carotene alone. Surprisingly, opposite effects on the-
se parameters were obtained using lycopene in association with
tar in the same range of b-carotene concentrations. In all the
cells analysed, lycopene acted as an antioxidant, inhibiting DNA
oxidative damage, cell growth and the expression of Cox-2.
Both b-carotene and lycopene were consumed by smoke. Ho-
wever, while the oxidation of lycopene reduced its antioxidant
and growth-inhibitory effects, the oxidation of b-carotene en-
hanced its prooxidant and growth-promoting activity, strongly
suggesting that oxidative metabolites of b-carotene may be
implicated in the control of cell growth. These findings support
the hypothesis that a redox mechanism may be implicated in
the regulation of cell growth by carotenoids and suggest a po-
ssible explanation for the detrimental effects of an association
of smoke and b-carotene found in human trials.
b-carotene-induced changes
in RARb isoform expression pattern
do not influence lung adenoma
multiplicity in the NNK-initiated
A/J mouse model
R. Goralczyk1, H. Bachmann2, K. Wertz1, B. Lenz2,
G. Riss1, P. Buchwald-Hunziker1, C.P. Aebischer1
1DSM Nutritional Products, R&D, Human Nutrition and Health,
2F. Hoffmann-La Roche Ltd., Basel, Switzerland
Dietary beta-carotene (bc) has been associated with de-
creased lung cancer risk, however intervention studies in smo-
kers reporting increased lung tumor rates after high long-term
bc supplementation. To establish reasons for these conflicting
results, we studied the influence of bc on tobacco smoke car-
cinogen-induced lung cancer development in the A/J-mouse
using 4-(N-Methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
(NNK) as initiator, and lung adenoma multiplicity as functional
endpoint. Gene regulation of the putative tumor suppressor
RARbeta was analyzed by quantitative Real-time PCR for its
relevance to predict the endpoint lung cancer.
A/J-mice achieved plasma bc levels of up to 3 micromol/L
within 4 weeks, and up to 6 micromol/L after 6 months of
supplementation on a diet modified to enhance bc absorption.
Despite high lung bc concentrations of up to 6 micromol/l/kg,
tumor multiplicity was not significantly affected by the bc tre-
atment, neither in carcinogen-initiated or in uninitiated mice,
and irrespective of dose and time point of treatment during
cancer formation. Tumor multiplicity was not correlated with
bc plasma levels in NNK-treated animals. All RARbeta isoforms
were significantly suppressed in lungs of NNK-treated animals
irrespective of bc treatment. However, the number of tumors
per mouse did not correlate with the RARbeta-isoform expres-
sion levels. Bc alone mildly but significantly increased RARbe-
ta1 and RARbeta2 and 4 after 3 months supplementation. This
induction persisted until 6 months for RARbeta2 and 4. In conc-
lusion, bc-induced change in RARbeta-isoform expression pat-
tern was not predictive for tumor multiplicity, but rather indi-
cative for an intact bc metabolism and persistent sensitivity to
retinoic acid in the mice.
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The effect of b-carotene in colon
and lung epithelial cells
N.L.W. Franssen-van Hal, J.E. Bunschoten,
 J.W. Molthoff, J. Keijer
RIKILT-Institute of Food Safety, Food Bioactives Group,
Wageningen, The Netherlands
We have studied the effect of b-carotene on gene expre-
ssion in intestinal and lung epithelial cells. First in vitro studies
were started in human cell lines. To make a selection of rele-
vant cell lines and exposure times, intracellular b-carotene and
metabolite levels were measured in a panel of human intesti-
nal and lung cell lines that were exposed to 1 µM b-carotene
during 2, 6, 30, 54 hours and 3 weeks. The panel included
three colorectal carcinoma cell lines (Caco-2, HT-29, HT29D4),
an SV40 transformed colon cell line (CCD 841 CoTr), an inte-
stinal carcinoma cell line (HuTu 80), three lung carcinoma cell
lines (NCI-H661, NCI-H292, NCI-H460) and an SV40 trans-
formed lung cell line (BEAS-2B). A single run HPLC method
was used for this purpose, which allowed simultaneous
measurement of intracellular carotenoid and retinoid levels.
The intracellular b-carotene levels varied between the cell li-
nes. The three colorectal carcinoma cell lines showed low le-
vels of b-carotene which linearly increased during the whole
exposure period of 3 weeks.  The remaining cell lines had much
higher intracellular b-carotene levels, which stabilized after
54 hours of exposure. Also metabolite profiles appeared to
diverge between the various cell lines.
Two lung cell lines were chosen for further gene expression
studies using cDNA microarrays, the lung carcinoma cell line
NCI-H661 and the SV40 transformed lung cell line BEAS-2B.
The cell lines were exposed to 1 µM b-carotene during
78 hours and RNA samples were hybridized to a 3K human
cDNA array to find up- and down-regulated genes. The chan-
ges in gene expression induced by the b-carotene exposure
appeared to be small (maximum 2.4 fold for NCI-H661 and 2.
1 fold for BEAS-2B). For both cell lines the number of differen-
tially expressed genes was small. NCI-H661 and BEAS-2B sho-
wed 16 and 20 differentially expressed genes, respectively,
more than 1.5 fold up- or down-regulated (p < 0.05, n = 5).
Different genes were found in the two cell lines. Principle Com-
ponent Analysis (PCA) showed that the basal gene expression
differences between the cell lines were bigger than the gene
expression changes induced by beta carotene, confirming
differences between the cell lines. The microarray results co-
uld be confirmed by Q-PCR. In addition to in vitro studies, gene
expression studies were performed in a ferret model in colla-
boration with Palou et al.
The effect of beta-carotene
and fatty acids on proliferation
and apoptosis of human melanoma
and prostate cancer cells
P. Laidler
Institute of Medical Biochemistry, Jagiellonian University
Medical College, Kraków, Poland
High doses of beta-carotene and other carotenoids have
been recognized for their anti-cancer activity, either because
of antioxidant potential or due to their possible conversion to
retinoic acids. Cellular responses to retinoids are generally
mediated by two families of nuclear receptors RARs and RXRs.
Fatty acids are common components of regular diet and also
do not remain without effect on a development and progre-
ssion of melanoma and prostate cancer. Several studies sugge-
sted that essential fatty acid and their metabolites can induce
apoptotic death of cell and this action seem to depend on their
ability to augment free radical generation and lipid peroxida-
tion. It has been proposed that the w-6 fatty acids increase the
rate of tumor growth. The essential fatty acids, linoleic acid and
arachidonic acid (AA), and the AA metabolite PGE2 stimulate
tumor growth while oleic acid and the w-3 fatty acid, eicosa-
pentaenoic acid inhibited growth in cancer cell line. Therefo-
re, we studied the effect of physiological concentration of ara-
chidonic acid and beta carotene on cell growth and gene expre-
ssion in human melanoma cell lines A 375 and WM 35 as well
as human prostate cancer LNCaP and PC-3.
Material and methods: Studies were carried on human can-
cer cell lines: A375, WM-35 — melanoma and LNCaP (andro-
gen dependent), PC-3 (androgen-independent) prostate can-
cer. The cells were stimulated by 10 mM, 20 mM BC and/or by
linoleic, arachidonic acid (0.5; 2 and 5 mM). The proliferation
cells was determined by ELISA BrdU and Crystal Violet Test
and cytotoxicity using LDH Test. The expression of genes was
studied using RT-PCR, real-time PCR and Microarray analysis
(Affymetrix HG-U133A; 22 000 genes). Protein expression was
monitored by Western blot.
Results: BC+AA decreased proliferation of LNCaP pro-
state cancer cells(~25–35%) as well as melanoma A 375 cells
(~25%). In case of LNCaP prostate cancer cells, microarray
analysis reviled that the expression of number of genes invo-
lved in replication, transcription and translation processes, ste-
roid metabolism, cholesterol and eicosanoid metabolism was
affected. We also observed decreased expression of c-myc,
MAD, MAX. and the changes in expression of the genes which
control the transition from G1 to S phase of cell cycle — cyto-
kines and CDK (up regulated with BC +AA), Rb and p107 (up
regulated with AA + BC) and E2F (down regulated with BC +
+ AA). Similarly, microarray analyses indicated that in melanoma
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BC + AA might affect cell growth also by modulation of gene
expression that control G1/S checkpoint (cyclins and their ca-
talytic subunits and gene involved in replication). This analysis
showed no direct correlation with the expression of cdk2 and
RB1 on protein levels. The data suggested, that BC + AA in-
duced cell cycle delay in G1 phase most likely by changes in
physiological activity of proteins involved in cell cycle progres-
sion.
1. The effect of arachidonic acid and beta carotene on human mel-
anoma cell growth. D. Gil1, W. Placha1, J. Dulińska1, A. Kieć-
-Dembińska2, G. Schmitz3, P. Laidler1
2. Prostate cancer and supplementation with fatty acid and beta
carotene: cell cycle regulation.  J. Dulińska1, D. Gil1, W. Placha1,
A. Dembińska-Kieć2, G. Schmitz3 P. Laidler1
This work was financially supported by grant: DLARFID, QRLT-
-2001-00183 (EU 5thFP).
The authors thank the DSM Nutritional Products for support.
Role of lycopene and tomato
products in prostate health
M. Stacewicz-Sapuntzakis, P.E. Bowen
Department of Human Nutrition, University of Illinois at
Chicago, Chicago, United States of America
Epidemiological evidence associating the decreased risk
of prostate cancer with frequent consumption of tomato products
inspired us to conduct a small intervention trial among patients
diagnosed with prostate adenocarcinoma. Tomato sauce pa-
sta was consumed daily for three weeks before their schedu-
led prostatectomy and biomarkers of tomato intake, prostate
cancer progression and oxidative DNA damage were followed
in blood and the available prostate tissue. The whole food in-
tervention was so well accepted by the subjects, that the blo-
od lycopene (the primary carotenoid in tomatoes responsible
for their red color) doubled and the prostate lycopene con-
centration tripled during this short period. Oxidative DNA
damage in leukocytes and prostate tissues was significantly di-
minished, the latter mainly in the tumor cell nuclei, possibly
due to the antioxidant properties of lycopene. Quite surprising
was the decrease in blood prostate-specific antigen, which was
explained by the increase in apoptotic death of prostate cells,
especially in carcinoma regions. Prostate cancer cell cultures
(LNCaP) were also sensitive to lycopene in growth medium,
which caused an increased apoptosis and arrested the cell cycle.
A possible explanation of these promising results may reside in
lycopene effects on the genes governing the androgen stimula-
tion of prostate growth, cytokines and on the enzymes produ-
cing reactive oxygen species, all of which were recently disco-
vered by nutrigenomic techniques. Other phytochemicals in to-
mato may act in synergy with lycopene to potentiate protective
effects and to help in the maintenance of prostate health.
The in vitro effect of b-carotene and
arachidonic acid on cytotoxicity,
proliferative potential, differentiation
and apoptosis on the acute myeloid
leukemia cells
T. Sacha, M. Zawada, M. Szostek, Z. Lach, J. Hartwich,
A. Balana-Nowak, E. Zdziłowska, G. Schmitz,
T. Langmann, A. Dembińska-Kieć, A.B. Skotnicki
Chair and Department of Haematology Jagiellonian University
Medical College, Kraków, Poland, Department of Clinical
Biochemistry Jagiellonian University Medical College, Kraków,
Poland, Institute of Clinical Chemistry University of Regensburg,
Regensburg (Germany)
Background: There is considerable evidence from cell cul-
ture and animal models experiments, that antioxidant vitamins
and related micronutrients are able to influence the carcinoge-
nic process. beta-carotene (BC) appears to have the strongest
protective effect in lowering the risk of cancer. Beta-carotene
can modulate molecular pathways involved in the cell cycle
progression and enhance the apoptosis. Several lines of evi-
dence indicate that arachidonic acid (AA) or its metabolites
are involved in modulating growth and survival of hematopoie-
tic cells. It is suggested that the regulation of differentiation,
proliferation and apoptosis of healthy cell differ significantly from
the cancer cell line fate. In recent years much interest has been
devoted to the carotenoids as factors playing essential role in
regulation of cellular mechanisms in normal and neoplasmatic
cells.
Aim of the study: This study was aimed to elucidate some
aspects of the beta-carotene and its derivatives such as prolife-
ration, differentiation and apoptosis of acute myeloid cells (AML).
Material and methods: Hematopoietic cells were obtained
from bone marrow biopsy of 8 de novo AML patients during
diagnostic procedures. Cells (1 × 106) were cultured in the
presence of BC (1, 3, microM) and AA (10 microM) for 24, 48,
72 and 96 hours. The cytotoxicity of respective test substan-
ces was measured using CytoTox 96; Non-Radioactive Cyto-
toxicity Assay (Promega, Madison, USA). The effect of beta-
carotene on cell cycle progression and/or apoptosis in leuke-
mic cells was performed using the Cell Proliferation ELISA BrdU
colorimetric test (Roche, Mannheim, Germany). The reaction
product was quantified by measuring the absorbance at re-
spective wavelength by a scanning multiwell spectrophotome-
ter. The flow cytometry method was used to check the diffe-
rentiation status of cells before and after all experiments using
murine anti-human antibodies: CD4, CD11b, CD13, CD14,
CD15, CD33, CD34, CD45, CD117 and HLA-DR (Becton
Dickinson, Mountain View, USA). A multicolor analysis of cell
surface molecules was measured using flow cytometer
FACSCalibur (Becton Dickinson, Mountain View, USA).
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Detection of the apoptotic cells was performed using Annexin
V Assay and TUNEL method (Pharmingen, San Diego, USA) with
FACSCalibur flow cytometer (Becton Dickinson, Mountain
View, CA). After 24 up to 96 h incubation with BC and AA,
colony forming unit-leukaemic (CFU-L) were assayed in me-
thylcellulose serum-free medium with growth factors: stem cell
factor, IL-3, IL-6, G-CSF and GM-CSF (Methocult, StemCell,
Canada) in 14 days in vitro cultures. All cultures were perfor-
med in duplicate and colony counts were performed on day 14.
Results: We did not observe the cytotoxic effect neither
of 1 and 3 microM concentration of beta-carotene nor of 10 mi-
croM concentration of arachidonic acid. Cytotoxicity of beta-
carotene was seen after incubation of studied cells with 10 mi-
croM concentration for 24 hours. For further experiments non-
toxic concentration of BC or AA was chosen (3 and 10 mi-
croM respectively). The 24, 48, 72 and 96 hour coincubation
of AML cells with BC and AA did not reveal any influence on
the cellular proliferation and the CFU-L number in the clono-
genic assay. Even 96 hours treatment of AML cells with BC
and AA did not reveal any influence on the cellular diferentia-
tion. The induction of cellular apoptosis by beta-carotene was
not seen in all AML patients. Conclusion: In this study we de-
monstrated that beta-carotene did not affect the proliferation,
differentiation and apoptosis of AML cells. The interesting ob-
servation is that the achievable in vivo concentration of  beta-
-carotene (10 microM) is cytotoxic for hematopoietic cells in
vitro.
Supported by the EU F5 DLARFID QLTR-2001-00183.
The authors thank the DSM Nutritional Products for support.
Cancer prevention by retinoids and
carotenoids: independent action on
a common target
J.S. Bertram, A.L. Vine
Cancer Research Center of Hawaii, University of Hawaii at
Manoa, Honolulu, Hawaii, United States of America
Virtually all human tumors are deficient in gap junctional
communication (GJC) and restoration of GJC by forced expres-
sion of connexins reduces indices of neoplasia. Expression of
connexin 43 (C × 43) is upregulated by cancer-preventive re-
tinoids and carotenoids which correlates with suppression of
carcinogen-induced transformation in 10T1/2 cells. However,
the molecular mechanism for upregulated expression is poorly
understood. The retinoic acid receptor antagonist, Ro 41-5253,
suppressed retinoid-induced C × 43 protein expression in
10T1/2 cells and induction of a C × 43 luciferase reporter con-
struct in F9 cells, but did not suppress protein expression or
reporter activity induced by the non-pro-vitamin A carotenoid
astaxanthin.  In contrast, C × 43 induction by astaxanthin, but
not by a RAR-specific retinoid, was inhibited by GW9662,
a PPAR-g antagonist. Neither compound required protein syn-
thesis for induction of C × 43 mRNA, nor was the 5.0 hour
half-life of C × 43 mRNA altered, indicating direct transcrip-
tional activation. The responsive region was found within –158
bp and +209 bp of the transcription start site. Site directed
mutagenesis of a GC-box in this region increased basal levels
of transcription and loss of retinoid responsiveness. Simulta-
neous treatment with a retinoid and b-carotene or astaxanthin
resulted in supra-additive C × 43 expression, again indicating
separate mechanisms of gene regulation.
Carotenoids in nutritional
protection
W. Stahl, H. Sies
Heinrich-Heine-University Düsseldorf, Institute of Biochemistry
and Molecular Biology I, Düsseldorf, Germany
Carotenoids comprise a class of natural fat-soluble pigments
which are found in numerous fruit and vegetables. Following
a diet rich in carotenoids has been epidemiologically correlated
with a lower risk for several diseases. The antioxidant activity
of carotenoids and biochemical properties influencing signa-
ling pathways have been discussed as basic mechanisms of pre-
vention. Conflicting data from intervention studies with b-ca-
rotene to prevent cancers and cardio-vascular disorders have
challenged the concept. However, there is still convincing evi-
dence that carotenoids are important components of the an-
tioxidant network. Photooxidative damage is suggested to be
involved in the pathobiochemistry of several diseases affecting
the skin and the eye and carotenoids may protect light-expo-
sed tissues. Lutein and zeaxanthin are the predominant caro-
tenoids of the retina and are considered to act as photopro-
tectants preventing retinal degeneration. The unique distribu-
tion, localization and high levels of both carotenoids within the
macula lutea as well as their physicochemical properties make
them suitable candidates for photoprotection. Beta-carotene
is used as an oral sun protectant for the prevention of sunburn
and has been shown to be effective either alone or in combi-
nation with other carotenoids or antioxidant vitamins. Protec-
tive effects are also achieved with a diet rich in lycopene. Ca-
rotenoids are important components of a healthy diet and con-
tribute within the network of vitamins and phytochemicals to
the maintainance of health.
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Are lycopene and other dietary
carotenoids beneficial? Reactions
of carotenoids with oxy-radicals
and singlet oxygen
T.G. Truscott, D. McGarvey, A. El-Agamey
School of Chemistry and Physics, Keele University, United
Kingdom
Carotenoids play diverse roles in biology and medicine.
Both the quenching of singlet oxygen (energy transfer) and in-
teraction with oxy-radicals (electron transfer, H-atom transfer
and addition reactions) are key processes in understanding many
of these roles and especially their roles as dietary supplements.
Previous work in ”simple” solvents will be reviewed and new
results in cell membrane models will be presented and discu-
ssed in terms of carotenoid structure, and their influence on
the properties of the lipid membrane. The formation
of aggregates by polar carotenoids is also proposed to be
of significance in their ability to quench singlet oxygen.
The possible consequences of using lycopene and other
carotenoids as dietary supplements will be discussed.
The authors thank the Leverhume Trust (Research Grant
F/00130F) for financial support.
Carotenoids as modulators of lipid
membrane physical properties
W.I. Gruszecki1, K. Strzałka2
1Department of Biophysics, Institute of Physics, Maria Curie-
-Skłodowska University, Lublin, Poland, 2Department of Plant
Physiology and Biochemistry, Faculty of Biotechnology,
Jagiellonian University, Kraków, Poland
Carotenoids are a group of pigments present both in plant
and animal kingdom, that play several important physiological
functions. The protection against active oxygen species reali-
sed via quenching of excited states of photosensitising molecu-
les, quenching of singlet oxygen and scavenging of free radicals
is one of the main biological functions of carotenoids. Several
recent research indicate that protection of biomembranes aga-
inst oxidative damage can be also realised via modification
of physical properties of the lipid phase of the membranes.
This work presents overview of research on an effect of caro-
tenoids on structural and dynamic properties of lipid membranes
carried out with application of different techniques such as Elec-
tron Paramagnetic Resonance, Nuclear Magnetic Resonance,
Differential Scanning Calorimetry, X-Ray diffractometry, mo-
nomolecular layer technique and other techniques. It appears
that in most cases polar carotenoids span lipid bilayer and have
their polar groups anchored in the opposite polar zones of the
membrane. Owing to the van der Waals interactions of rigid
rod-like molecules of carotenoid and acyl chains of lipids pig-
ment molecules rigidify the fluid phase of the membranes and
limit oxygen penetration to the hydrophobic membrane core
susceptible to oxidative degradation.
Model and cellular in vitro study
of antioxidant and photoprotective
properties of macular pigments
M. Wrona-Krol1, M. Rozanowska1, W. Korytowski1,
T.G. Truscott2 , T. Sarna1
1Department of Biophysics, Faculty of Biotechnology,
Jagiellonian University, Kraków, Poland, 2Department
of Chemistry, School of Chemistry and Physics, Keele University,
Keele, United Kingdom
A growing body of epidemiological data suggests that the
amount of lutein and zeaxanthin, the two most prominent pig-
ments of the macula lutea, inversely correlates with the inci-
dence of age-related macular degeneration (AMD), the major
cause of blindness in people over 60 in developed Western
countries. Although the exact mechanism of this phenomenon
remains to unknown, experimental data obtained in model sys-
tems of different complexity indicate the role of macular pig-
ments in protecting the retina against oxidative stress that may
be involved in the pathogenesis of AMD. In this study, we exa-
mined antioxidant efficiency of zeaxanthin in protecting lipo-
somal membranes against oxidative damage induced by aero-
bic photoexcitation of Rose Bengal and ARPE-19 cells against
photodynamic damage mediated by Merocyanine 540. Progress
of photosensitized peroxidation of lipids in multilayer liposo-
mes made of DMPC/POPC and cholesterol, was monitored
by EPR-oximetry and HPLC-EC(Hg) determination of lipid
hydroperoxides. Cell survival was determined by MTT assay
and cell membrane damage was assessed by HPLC-EC(Hg)
determination of cholesterol hydroperoxides using the endo-
genous cholesterol as a mechanistic reporter molecule.
The efficiency of zeaxanthin, vitamin E and vitamin C in protecting
against singlet oxygen and free radicals, generated by photo-
sensitized oxidation reactions, was determined by measuring
singlet oxygen- or free radical-specific products of cholesterol
oxidation. We found that in model membranes, zeaxanthin was
a very efficient quencher of singlet oxygen. Although this caro-
tenoid was rapidly consumed due to interaction with free radi-
cals, combination of zeaxanthin with vitamin E or vitamin C
exerted a synergistic protection against both singlet oxygen
and free radical dependent oxidation of model and cellular
membranes. Cells with added antioxidants, exhibited increased
resistance to photodynamic damage and accumulated less
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lipid hydroperoxides. The data indicate the importance of the
antioxidant interaction in protection against oxidative damage
to cell membranes.
Supported by KBN and EC Vth Framework Programme.
Roles of PPAR delta in lipid
absorption and metabolism: a new
target for the treatment of type 2
diabetes
S. Luquet, C. Gaudel, D. Holst, J. Lopez-Soriano,
C. Jehl-Pietri, A. Frendenrich, P.A. Grimaldi
INSERUM U470, Centre de Biochemie, Nice, France
Peroxisome proliferator-activated receptors (PPARs) are
lipid-activated transcription factors exerting several functions
in development and metabolism. PPARalpha, activated by po-
lyunsaturated fatty acids and fibrates, is implicated in regula-
tion of lipid metabolism, lipoprotein synthesis and metabolism
and inflammatory response in liver and other tissues.
PPARgamma plays important roles in regulation of prolifera-
tion and differentiation of several cell types, including adipose
cells. Its activation by thiazolidinediones results in insulin sensi-
bilization and antidiabetic action. Until recently, the physiolo-
gical functions of PPARdelta remain elusive. The utilization
of specific agonists and of appropriate cellular and animal models
revealed that PPARdelta has an important role in metabolic
adaptation of several tissues to environmental changes. Treat-
ment of obese animals by specific PPARdelta agonists results in
normalization of metabolic parameters and reduction of adi-
posity. The nuclear receptor appeared to be implicated in the
regulation of fatty acid burning capacities of skeletal muscle
and adipose tissue by controlling the expression of genes invo-
lved in fatty acid uptake, beta-oxidation and energy uncoupling.
PPARdelta is also implicated in the adaptive metabolic respon-
se of  skeletal muscle to endurance exercise by controlling the
number of oxidative myofibers. Given the results obtained with
animal models, PPARdelta agonists may have therapeutic use-
fulness in metabolic syndrome by increasing fatty acid consump-
tion in skeletal muscle and adipose tissue.
A novel method for rapid
quantification of free and esterified
phytosterols in serum using APPI
tandem mass spectrometry
J. Thiery, U. Ceglarek, J. Lembcke, G.M. Fiedler
Institute of Laboratory Medicine, Clinical Chemistry and
Molecular Diagnostics, University Hospital, Leipzig, Germany
Recent studies suggest that even modest elevations of se-
rum phytosterols may be associated with an increased athero-
sclerotic risk. However, further large-scale studies are manda-
tory to prove the role of phytosterols as an additional athero-
sclerotic risk factor. For this purpose sensitive high throughput
analytical methods are necessary.
A novel analytical platform based on liquid chromatogra-
phy and tandem mass spectrometry (LC-MS/MS) using atmo-
spheric pressure photoionization (APPI) was applied for the
simultaneous quantification of free and esterified b-sitosterol,
campesterol, brassicasterol, and stigmasterol.
The total time for sample pretreatment and analysis could
be reduced from about three hours (gas chromatography-mass
spectrometry, GC-MS) to 15 minutes. The detection limits
of the different phytosterols ranged between 0.25 and 0.68  µg/l.
Linear ranges were between 1 and 1000  µg/l. The within and
between-run variability ranged between 1.4 and 9.9%.
The analytical sensitivity was at least 150 fold higher compared
to GC-MS. Using our novel LC-MS/MS platform, serum phyto-
sterol levels in 49 healthy volunteers were in the same range
as those reported by other authors using GC-MS. Campeste-
rol serum mean concentrations of 3.2 mg/l (20) and 5.2 mg/l
(1.5–9.7 mg/l) (21) were reported. For b-sitosterol mean serum
concentration s of 2.7 mg/l (20) and 3.6 mg/l (0.8–6.6 mg/l)
(21) were found. In comparison, we found a mean total cam-
pesterol serum concentration of 4.53 mg/l (1.96–12.27 mg/l)
and a mean total b-sitosterol concentration of 2.43 mg/l (1.01–
–6.07 mg/l).
In conclusion, our new analytical platform allows a rapid
determination of phytosterols and their corresponding esters
in small serum volumes without extensive sample pre-treat-
ment. Therefore, our new method is especially suited for lar-
ge-scale clinical and animal studies to evaluate the role of phy-
tosterols as an additional CHD risk factor.
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Synergistic effects of zeaxanthin and
its binding protein in the prevention
of lipid membrane oxidation
P. Bhosale, P.S. Bernstein
Moran Eye Center, University of Utah School of Medicine,
Salt Lake City, Utah, United States of America
There is growing evidence that high levels of the macular
xanthophyll carotenoids lutein and zeaxanthin may be protec-
tive against visual loss due to age-related macular degenera-
tion, but the actual mechanisms of their protective effects are
still poorly understood.  We have recently purified, identified
and characterized a pi isoform of glutathione S-transferase
(GSTP1) as a zeaxanthin-binding protein in the macula of the
human eye which specifically and saturably binds to the two
forms of zeaxanthin endogenously found in the foveal region
(Bhosale et al. 2004). In this report, we studied the synergistic
antioxidant role of zeaxanthin and GSTP1 in egg yolk phospha-
tidylcholine (EYPC) liposomes using hydrophilic 2,2c-azobis
(2-methyl-propionamidine) dihydrochloride (AAPH) and lipophi-
lic 2,2c-azobis(2,4-dimethylvaleronitrile) (AMVN) as lipid peroxi-
dant initiators. The two zeaxanthin diastereomers displayed sy-
nergistic antioxidant effects against both azo lipid peroxidant ini-
tiators when bound to GSTP1.  In the presence of GSTP1, non-
-dietary (3R,3cS-meso)-zeaxanthin was observed to be a better
antioxidant than dietary (3R,3cR)-zeaxanthin. This effect was fo-
und to be independent of the presence of glutathione. Caroteno-
id degradation profiles indicated that the zeaxanthin diastereomers
in association with GSTP1 were more resistant to degradation
which may account for the synergistic antioxidant effects.
Induction of PXR-mediated
metabolism by b-carotene
R. Rühl
Department of Biochemistry and Molecular Biology, Medical and
Health Science Center, University of Debrecen, Debrecen, Hungary
Beta-carotene is the major carotenoid in the human nutri-
tion and is present in the human organism in micro-molar con-
centrations. Besides its function as pro-vitamin A b-carotene
has been shown to be an activator of the human pregnan X
receptor (PXR). This PXR is mainly expressed in the liver and
an inducer of enzymes involved in phase I, II and III metabo-
lism. The presentation is focused on the evaluation of physio-
logical and nutritional relevance of b-carotene as an inducer
of phase I enzymes in the human organism via PXR-mediated
mechanisms. Beneficial and detrimental effects of b-carotene
on xenobiotica metabolism and metabolism of various other
derivatives will be discussed.
Association of adipose and red blood
cell lipids with severity of dominant
Stargardt macular dystrophy
P.S. Bernstein1, A.F. Hubbard2, E.W. Askew2,
N. Singh3, M. Leppert3
1Moran Eye Center, 2Department of Foods and Nutrition,
3Department of Human Genetics, University of Utah,
Salt Lake City, Utah, United States of America
The goal of this study was to determine whether or not
adipose and red blood cell lipids, particularly long-chain poly-
unsaturated fatty acids, such as docosahexaenoic acid (DHA)
and eicosapentaenoic acid (EPA), are significantly correlated
with phenotype in a family with autosomal dominant Stargardt-
like macular dystrophy. A mutation in the ELOVL4 gene is res-
ponsible for the macular dystrophy present in this family via its
possible involvement in fatty acid elongation in the retina (Bern-
stein et al. 2001).
The subjects in this study are eighteen adult family mem-
bers known to have a two base-pair deletion in the ELOVL4
gene. Each subject received a complete eye examination, inc-
luding fundus photographs, the results of which were used to
grade the subject’s severity on a three-tier scale. A blood sam-
ple was collected from each subject to examine red blood cell
lipids, an indication of short-term dietary fatty acid intake.
An adipose tissue sample was collected from fourteen of the
eighteen subjects as an indication of long-term dietary fatty acid
intake. The adipose and red blood cell lipids were analyzed
using capillary gas chromatography with mass spectrometry
detection (GC/MS).  The subjects also completed a self-admi-
nistered food frequency questionnaire.
When adipose lipids were analyzed, there was a significant
inverse relationship between phenotypic severity and EPA
(p = 0.04). When red blood cell lipids were analyzed, there
were significant inverse relationships between phenotypic se-
verity and EPA (p = 0.02) and DHA (p = 0.04). There were
no significant correlations between dietary fat intake and phe-
notype when the food frequency questionnaire was analyzed.
These initial results indicate that the phenotypic diversity pre-
sent in this family may be related to differences in dietary fat inta-
ke, as reflected by adipose and red blood cell lipids.  To our know-
ledge, this is the first demonstration that dietary factors can influ-
ence the severity of an inherited human macular dystrophy.
Bernstein PS, Tammur J, Singh N et al. (2001) Diverse macular
dystrophy phenotype caused by a novel complex mutation in the
ELOVL4 gene. Investigative Ophthalmology and Visual Science 42,
3331–3336.
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The risk polymorphisms
of ucp1 and PPARG2 genes
in patients with polycystic ovary
syndrome
B. Bendlova1, D. Sramkova1, M. Vankova1,
P. Samalikova1,  J. Vcelak1, S. Stanicka1, K. Dvorakova1,
K. Vondra1, D. Cibula2, J. Vrbikova1
1Institute of Endocrinology, Prague, Czech Republic,
2Clinic of gynecology and obstetrics, 1st Medical Faculty,
Charles University, Prague, Czech Republic
Aims: The A-3826G gene polymorphism of the uncoupling
protein 1 (UCP1) causes the lower expression of UCP1 in
the visceral fat and therefore the reduced energy expenditure.
Peroxisome proliferator activated receptor gamma 2 (PPARG2)
plays a role in the regulation of the adipocyte differentiation
and energy balance. The Pro12Ala polymorphism is associated
with insulin sensitivity. Since polycystic ovary syndrome (PCOS)
is often accompanied with obesity and insulin resistance we
decided to study the role of these selected polymorphisms
(SNPs) in the pathogenesis of PCOS. Therefore, we determi-
ned these polymorphisms in Czech PCOS patients and mat-
ched controls. The aim of the study was to compare the allelic
and genotypic distribution between these groups and to study
the possible association of the polymorphisms with screened
biochemical and anthropometric parameters.
Material and methods: The study entered 142 PCOS pa-
tients (age 27.0 ± 7.3) and 114 healthy control women (age
27.2 ± 6.1). The well biochemically and anthropometrically
characterized PCOS patients and controls underwent the oral
glucose tolerance test and the euglycemic hyperinsulinemic
clamp in 50 PCOS patients was performed. The  A-3826G (AG)
and Pro12Ala (PA) SNPs were detected by PCR-RFLP method.
The statistical analyses were done using NCSS 2000 software.
Results: The genotype frequencies in PCOS and controls
were: UCP1 AA: 53% vs. 49.5%; AG: 39% vs. 40%, GG: 8%
vs. 10.5%, PPARG2 PP: 79% vs. 76%, PA: 17% vs. 23%, AA:
4% vs. 1%. Despite the fact that PCOS patients had signif.
higher androgene levels, higher BMI, WHR, lipid levels, fasting
and stimulated glycaemia and insulinaemia, lower SHBG,
1/HOMA R, Matsuda and QUICKI indeces in comparison to
controls, the genotypic frequencies did not differ between the
groups (UCP1  c2 = 0.6, NS; PPARG2 c2 = 3.10, NS). Even
though the increase of BMI in G allele carriers in the control
group was apparent (UCP1 AA vs. AG p = 0.03, AA vs. GG p =
= 0.02), this trend was not found in the PCOS patients. Pro12Ala
polymorphism was not associated with insulin sensitivity.
Conclusion: Our study did not confirm the association of
A-3826G and Pro12Ala polymophisms with PCOS.
This work was supported by grants GACR 301/04/1085 and
COSTOC B17.10 MSMT CR.
Insulin resistance and the beta-cell
function in relation to selected DM 2
candidate genes
M. Vankova, D. Sramkova,
P. Samalikova, J. Vcelak, H. Kvasnickova, K. Vondra,
B. Bendlova
Institute of Endocrinology, Prague, Czech Republic
Background and aims: Primary pathogenic causes of dia-
betes mellitus type 2 (DM2) are still not known, but the final
common pathway is the decreased ability of peripheral tissues
to respond to insulin (insulin resistance) and at the same time
the loss of pancreatic beta-cell ability to compensate it by in-
crease of insulin secretion. Relation between beta-cell func-
tion (BF) and insulin resistance (IR), resp. sensitivity (IS), de-
scribe disposition indices (DI = BF * IS).
Materials and methods: A total of 292 unrelated subjects
with varying degrees of glucose tolerance were clustered on
the basis of similarity of disposition index. DI was calculated
from stimulated OGTT values of glycemia and insulin (BF: in-
sulinogenic index and IS: Matsuda index, as we described pre-
viously in Vrbikova at al. Diabetes Care 25 (7), 2002). The clu-
sters consisting of subjects under 25 percentile (cluster 1) and
above 75 percentile (cluster 2) of DI value distribution were
compared according to biochemical parameters and anthro-
pometric characteristics. The SNPs of INS VNTR (HphI), FABP2
(HpaI), PPAR gama (HgaI), Beta2AR (MvaI), Beta3AR (MvaI),
Kir6.2 (BanII) and UCP1 (BclI) were determined by PCR-RFLP
and genotype and allele frequences were compared using non-
parametric Mann-Whitney test. Statistical analyses were done
by NCSS 2001 program.
Results: Cluster 1 consists of 58 subjects with sex ratio 23
M/35 F, family history of DM2 ratio (first degree) 29 yes/29 no
and mean age 37.07 ± 12.55. Cluster 2 consists of 58 subjects
with sex ratio 23 M/35 F, family history of DM2 ratio 17 yes/41
no and mean age 32.43 ± 10.87. The differences between clu-
sters were not observed in age and sex ratio, but in cluster 1
were significantly more subjects with positive family history of
DM2 than in cluster 2 (p = 0.019). Cluster 1 comprises sub-
jects with significantly higher triacylglycerols (1.24 ± 0.63
vs. 0.84 ± 0.41, p = 0.0002) and serum uric acid (292.17 ± 86.47
vs. 262.48 ± 74.69, p = 0.047) than subjects in cluster 2. Men
and women in cluster 1 had significantly WHR (men 0.89 ±
± 0.08 vs. 0.81 ± 0.04 and women 0.77 ± 0.09 vs. 0.72 ± 0.05;
p = 0.0014, resp. p = 0.015). Women in cluster 1 had also
lower muscle to subcutaneous fat ratio than women in cluster 2
(1.51 ± 0.55 vs. 1.89 ± 0.68, p = 0.028). Differences in geno-
type and allele frequecies between clusters were observed only
in E23K SNP of Kir6.2 gene (Fisher exact test). In cluster 1
compared to cluster 2 were identified genotype EE in 10
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(20.8%) vs.18 (37.5%), genotype EK in 27 (56.3%) vs. 28
(58.3%) and genotype KK in 11 (22.9%) vs. 2 (4.2%) subjects,
p = 0.014. Allele frequencies in cluster 1 compared to cluster 2
were E 49% vs. E 66.7% and K 51% vs. 33.3%, p = 0.013.
Conclusion: Better characteristics of BF and IR in non-dia-
betic subjects arise from stimulated OGTT values. Clusters ge-
nerated on the basis of DI value are sifnificantly different in
some biochemical and anthropometric parameters. Higher fre-
quency of K allele of Kir6.2 gene in cluster with lower DI is in
agreement with described positive association of K allele with
decreased BF. Higher frequency of the subjects with positive
family history of DM2 in the cluster with lower DI, which pro-
vides evidence of the glucose tolerance status, revealed, that
stimulated DI is valid criterion for detecting of early stages
of impaired glucose tolerance.
This work was supported by grants IGA MH CR NR/7809-5
and COST OC.B17.10.
The KCNJ11 gene polymorphism
E23k in Relation To DM2
in Czech population
D. Sramkova, M. Vankova, P. Samalikova, J. Vcelak,
V. Hainer, B. Bendlova
Institute of Endocrinology, Prague, Czech Republic
Aims: The KCNJ11 (Kir 6.2) gene product is a pore-for-
ming subunit of the inwardly rectifying ATP sensitive K+ chan-
nel, which is involved in the regulation of insulin secretion.
KCNJ11 E23K polymorphism is considered as a DM2 risk alte-
ring SNP. Therefore, we decided to determine allelic and ge-
notypic frequencies of the polymorphism in DM2 patients, in
offsprings of DM2 patients, and in healthy adult Czech popula-
tion. The aim was to compare genotypic distribution between
these groups and to study the possible association of the poly-
morphism with biochemical and anthropometric parameters
related to DM2.
Material and methods: The study entered 293 DM2 patients
(age 58.67 ± ± 7.10; BMI = 30.55 ± 5.52 kg/m2), 108 offsprings
(age 37.91 ± ± 10.54; BMI = 25.35 ± 4.24 kg/m2), and 177
control subjects (age 32.31 ± 10.61; BMI = 23.31 ± 3.67 kg/m2).
The E23K substitution was detected by PCR-RFLP method
(BanII). The statistical analyses were performed using NCSS
2000 and Statgraphics-plus software.
Results: The 23K allele frequency did not differ between
the group of diabetics, offsprings, and controls (38.23%,
40.28%, and 39.55%, resp.). However, genotypic distribution
in controls was significantly different in comparison with of-
fsprings (EE/EK/KK: 40.11%/40.68%/19.21% vs. 31.48%/
/56.48%/12.04%, resp. c2=7.04; p=0.03). Genotypic fre-
quencies in diabetics (36.52%/50.51%/12.97%) did not differ
significantly from controls (c2 = 5.46; p = 0.07). The asses-
sment of insulin levels and beta-cell function using the oGTT
derived indices in offsprings did not provide any evidence of
functional reduction neither in EK nor in KK genotypes. But, in
the control group, the KK genotype exhibited in comparison
with the EE genotype higher stimulated glucose levels (G30:
p = 0.001; G60: p = 0.001; G90: p = 0.003) and lower insuli-
nogenic index (I30-I0/G30-G0: p = 0.012) as well as lower
disposition indices.
Conclusions: The association of the KCNJ11 E23K poly-
morphism with DM2 was not confirmed. Nevertheless, in he-
althy adult subjects without family history of DM2, the KK car-
riers exhibited significant reduction in the insulinogenic index
as well as in disposition indices.
This work was supported by grants MSMT COST OC B17.10,
MZ 000000023761.
The additive effect of coexistence
more than one “susceptibility gene”
alleles on development of obesity
and insulin resistance
I. Wybrańska, M. Malczewska-Malec, M. Szopa,
M. Kwaśniak, A. Zdzienicka, A. Dembińska-Kieć
Department of Clinical Biochemistry Collegium Medicum,
Jagiellonian University, Kraków, Poland
Several quantitative trait loci have been associated with
different features of the metabolic syndrome and the genetic
susceptibility have been suggested for multiple polymorphisms
in a number candidate of genes. In our study the following gene
polymorphism’s: PPAR-g2, LPL, FABP-1, b2AR, b3AR, DRD2,
MCR-3, MCR-4, UCP-1, HSP-70, TNF-a,  and apoCIII were
analyzed. Several of these genes are involved in direct nutrient
interactions, suggesting potential targets for diet modification
therapies and the dietary fat is a single most important envi-
ronmental factor that can modify the impact of the metabolic
syndrome. The results of standardized meal (80 g of total fat)
on the triglicerides, free fatty acids, insulin and leptin level up
to 8 hours were analyzed.
The 250 members of 90 obese families (South Poland) par-
ticipated in the study. Moreover, because the family members
tend to share a similar environment, therefore in our study we
can also shown the existence of strong gene-gene interactions
which highly influenced the phenotype. For example, the phe-
notype of the group which characterize existence of two se-
lected homozygous polymorphism’s at risk compared to
group of the protective genotype demonstrated strong difference
in the several components of metabolic syndrome (parame-
ters of obesity, insulin resistance and hypertension). Moreover
the additive effect of coexistence more than one “susceptibili-
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ty gene” alleles on the development of metabolic syndrome
was also observed.
The gene-gene interaction highlight also the importance
of studies examining the effects of common genetic polymor-
phisms within the context of dietary factors. Different genetic
backgrounds of various geographic, ethnic or social popula-
tions justify the undertaking of large screening programs aimed
at the characterization of the genetic variability as it may lead
to the development of the targeted nutritional interventions.
This work was supported by Ministry of Informatics and Science
grants 4P05D08424; 4P05D01016; 501/Pkl/113/L, 501//Kl/563/L,
WŁ130/P/L.
Prostate cancer and supplementation
with fatty acid and beta-carotene:
cell cycle regulation
J. Dulińska1, P. Laidler1, D. Gil1, W. Placha1,
A. Dembińska-Kieć2, G. Schmitz3
1Institute of Medical Biochemistry, 2Department of Clinical
Biochemistry, Jagiellonian University Medical College, Kraków,
Poland, 3Department of Clinical Chemistry and Laboratory
Medicine, University of Regensburg, Regensburg, Germany
Prostate cancer is the most common malignancy in men
and mortality second only to lung cancer. Prostate tumors are
among the most heterogeneous of cancers, both histologically
and clinically. The androgen-dependent cancer cells initiate an
apoptotic cascade upon androgen ablation, but the androgen-
independent cells continue to proliferate. In addition, the dif-
ferent expression of a wild-type p53 and Rb tumor-supressor
genes was observed. In prostate cells, the processes of prolife-
ration, differentiation and programmed cell death processes
are regulated at least in part by androgens.
Beta carotene is believed to be an effective cancer-pre-
venting nutrient. The ability of beta-carotene to modulate the
carcinogenic process, at least in vitro, may be due, in part, to its
conversion to retinoids in human prostate cell lines and acting
through nuclear receptor with a similar mechanism to steroid
hormones that have plays an important role in prostate biolo-
gy. Fatty acids are common components of regular diet also
do not remain without effect on a development and progres-
sion of prostate cancer. It has been proposed that the omega-
6 fatty acids increase the rate of tumor growth. The essential
fatty acids, linoleic acid and arachidonic acid (AA), and the AA
metabolite PGE2 stimulate tumor growth while oleic acid and
the omega-3 fatty acid, eicosapentaenoic acid inhibited growth
in cancer cell line. Therefore we studied the effect of BC and
AA on prostate cancer.
Material and methods: Studies were carried out on LNCaP
androgen-dependent cell line. The cells were treated by 10 mM
POSTER SESSION
b-carotene (BC) in THF/ethanol and by 2.0 mM arachidonic acids
(AA) each separately or added together. The proliferation
of cells was determinated by ELISA BrdU and Crystal Violet Test
and cytotoxicity using Cytotoxicity Detection Kit (Roche).
The expression of genes was studied using microarray analysis
(Affymetrix HG-U133A; 22 000 genes), RT-PCR and real-time PCR
methods. Protein expression was monitored by Western blot.
Results: The changes in gene expression induced by BC
and AA in LNCaP prostate cancer cell line indicated that
BC+AA decreased proliferation (~25–35%) of LNCaP pro-
state cancer cells. The expression of number of genes involved
in replication, transcription and translation processes, steroid
metabolism (APRIN, FOLH, PTOV, KLK, PLAB, AR, SRD5A,
AKR and SREB), cholesterol (PGD) and eicosanoid metabo-
lism was affected. We also observed decreased expression
of c-myc, MAD, MAX when BC + AA were used together (de-
creased proliferation). We noticed the changes in expression of
the genes which control G1/S checkpoint — cytokines and CDK
(up regulated with BC +AA), Rb and p107 (up regulated with
AA + BC) and E2F (down regulated). This observation may
explain differences in proliferation of prostate cancer cells tre-
ated with BC and/or AA and indicates on strong link between
BC/AA treatment and regulation of cell cycle G1/S checkpoint.
This work was financially supported by grants: DLARFID,
QRLT-2001-00183 (EU 5thFP).
The authors thank the DSM Nutritional Products for support.
Different effect of beta-carotene on
proliferation of prostate cancer cells
J. Dulińska1, D. Gil1, J. Zagajewski1, J. Hartwich2,
M. Bodzioch2, A. Dembińska-Kieć2, T. Langmann3,
G. Schmitz3, P. Laidler1
1Institute of Medical Biochemistry, 2Department of Clinical
Biochemistry, Jagiellonian University Medical College, Kraków,
Poland, 3Department of Clinical Chemistry and Laboratory
Medicine, University of Regensburg, Regensburg, Germany
Beta-carotene is the most important precursor of retinol
and other retinoids whereas carotenoids serve as well for se-
veral other functions, such as radical quenching, antioxidant
and anti-carcinogenic activities and as regulators of the cell pro-
liferation. Retinoids control the growth, differentiation, and
apoptosis of cells during embryonic development and througho-
ut life. Acting similarly to hormones, they affect epidermal cell
growth, differentiation and sebaceous gland activity, as well as
have immunomodulatory and anti-inflammatory properties.
The carotenoids present in vegetables and fruits may be re-
sponsible for potential cancer-preventing action by inhibiting
the growth of tumor cells. Prostate cancer has become the
second leading cause of cancer-related death among men in
most Western countries. However, relatively little information
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concerning native in vivo vitamin A dynamics in human prostate
tissue is available and even less is known about how certain
retinoid therapies and interactions might affect native vitamin
A stores or the flux of the vitamin through this tissue. It was
shown that high doses of beta-carotene (> 30 µM) decrease
proliferation of prostate cancer cells in vitro. However, it is
rather doubtful whether such concentration of beta carotene
is really accessible at cellular level. We studied the effect of 3,
10 and 20 µM beta-carotene on proliferation and gene expres-
sion in LNCaP and PC-3 prostate cancer cell lines.
Material and methods: Studies were carried out on LNCaP
androgen-dependent and PC-3 androgen independent cell li-
nes. The cells were treated by: 3 µM, 10 µM and 20 µM beta-
-carotene in THF/ethanol 0.3 µM, 1 µM, 3 µM All-Trans Reti-
noic Acid and 9-cis Retinoic Acid in ethanol. Uptake of BC by
cells incubated for 24–72 hrs in various media analysis was stu-
died using HPLC assessment of beta-carotene in media and
cell extracts. The proliferation of cells was determined by ELI-
SA BrdU and Crystal Violet Test Cytotoxicity using Cytitoxici-
ty Detection Kit. The expression of genes was studied using
microarray analysis (Affymetrix HG-U133A; 22 000 genes), RT-
-PCR and real-time PCR methods. Expression of RB, CDK2,
c-myc, bax, bcl-2 was also studied on protein level (Western blot).
Results: Beta carotene — more efficiently absorbed from
medium by androgen sensitive LNCaP cells — increased pro-
liferation of LNCaP cells whereas it had weaker effect on
PC-3 cells. Initial global analysis of expression of genes in both
cell lines treated with 10 µM beta-carotene showed remarka-
ble differences in number of responsive genes. Their recogni-
tion allows for conclusion that differences between prostate
cancer cell lines in response to beta-carotene treatment are
due to various androgen sensitivities of LNCaP and PC-3 cells.
Detailed analysis of expression of selected genes in beta caro-
tene treated LNCaP cells at the level of mRNA and protein
indicated that the observed increase of proliferation could have
been the result of slight induction of a few genes affecting pro-
liferation (c-myc, c-jun, c-fos) and apoptosis (bcl-2) with no
significant effect on major cell cycle control genes (cdk2, RB,
E2F-1).
The authors thank the DSM Nutritional Products for support.
This work was financially supported by grants:DLARFID,
QRLT-2001-00183 (EU 5thFP).
The effect of arachidonic acid and
beta-carotene on human melanoma
cell growth
D. Gil1, W. Placha1, J. Dulińska1, A. Dembińska-Kieć2,
G. Schmitz3, P. Laidler1
1Institute of Medical Biochemistry, 2Department of Clinical
Biochemistry, Jagiellonian University Medical College, Kraków,
Poland, 3Department of Clinical Chemistry and Laboratory
Medicine, University of Regensburg, Regensburg, Germany
Beta-carotene and other carotenoids in high doses have
been shown to have anti-cancer activity, either because of an-
tioxidant activity or due to their possible conversion to reti-
noic acids. Several studies suggested that essential fatty acid
and their metabolites can induce apoptotic death of tumor cell
and this action seem to depend on their ability to augment free
radical generation and lipid peroxidation. The relation betwe-
en diet and carcinogenesis has not been presented in sufficient
detail to allow recognizing the mechanism of regulation the
cell proliferation. In particular no data reported that beta ca-
rotene and arachidonic acid were able to control cell prolifera-
tion or expression of genes in melanoma cells. Therefore, the
effect of physiological concentration of arachidonic acid and
beta carotene on cell growth and gene expression in human
melanoma cell line A 375 was investigated
Material and methods: Studies were carried on human me-
lanoma cell line A 375 (from tumor metastasis phase). The cells
were treated 3 µM, 10 µM, 20 µM beta carotene (BC) and/or
by arachidonic acid (AA) — 0.5, 2, and 5 µM. The proliferation
of cells was determined by ELISA BrdU and Crystal Violet Test
and cytotoxicity using LDH Test. The gene expression was stu-
died using RT-PCR and Microarray Affymetrix HG-U133a (22
000 genes) and proteins expression (Western Blott).
Results: BC and AA alone, increased incorporation of BrdU
but without increase in cell number. BC treatment had no an-
tiproliferative or cytotoxic effect because BC did not affect the
genes essential for cellular growth. AA regulated gene expres-
sion which are responsible for the G2/M transition in cell cycles
(Cdc2 cyclin B1 and Cdc2 – cyclin B2 or Cdc25) but had no
antiproliferative effect. Microarray analyses indicated that BC +
+ AA might affect cell growth by modulation of gene expres-
sion that control the transition of cells from G1 to S phase (cyc-
lins and their catalytic subunits and gene involved in replica-
tion). This analysis showed no direct correlation with the
expression of cdk2 and RB1on protein levels. We also obse-
rved decreased incorporation of BrdU without effect on the
expression of apoptotic proteins Bax/Bcl2, caspases or inhibi-
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tors of apoptosis (surviving). These data suggested, that BC +
+ AA induced cell cycle delay in G1 phase most likely by changes in
physological activity of proteins involved in cell cycle progression.
The authors thank the DSM Nutritional Products for support.
This work was financially supported by grants: DLARFID,
QRLT-2001-00183 (EU 5thFP).
Retinoid signaling promoted
by apocarotenals and beta-carotene
in BEAS-2B human
bronchioepithelial cells
E. Kuntz1, U. Hoeller2, B. Greatrix1, C. Lankin1,
N. Seifert1, S. Acharya1, G. Riss1, P. Buchwald-Hunziker1,
W. Hunziker1, R. Goralczyk1, K. Wertz1
1DSM Nutritional Products, R&D, 2Department of Human
Nutrition and Health, Basel, Switzerland
In two large human intervention trials in smokers, beta-
-carotene (bc) supplementation was associated with an incre-
ased risk for lung cancer. One hypothesis is that apocarotenals
are generated via oxidative breakdown of bc by smoke. This
would result in inhibited retinoic acid (RA) signaling, leading to
squamous metaplasia and cell proliferation. To test this, we
compared the effect of retinoids, apocarotenals or bc on RA
target gene expression using transcriptomics.
BEAS-2B cells were supplemented with physiological con-
centrations of all-trans-, 9-cis- and 4-oxo-RA, retinol, 4-oxo-
retinol and bc, 4’-, 8’-, 10’- and 12’-apocarotenals for up to
120 h. Cellular contents of the compounds was analysed by
HPLC. Gene expression after 72 h of treatment was analyzed
with Affymetrix GeneChip® technology. Key findings were ve-
rified by TaqMan® real-time RT-PCR.
Bc was taken up in a time- and dose-dependent manner.
b-Apo-10’-carotenal also accumulated time dependently in the
cells. No accumulation of retinoids was measured in the cells,
except retinol, leading to detectable levels of 9-cisRA and RA.
Microarray analysis revealed expected activities of retinoids by
upregulating known RA target genes involved in differentiation
(TGM2, MucinA3, Keratins), RA signaling (RARa, CRABP2,
RARRES1 and RARRES3) and developmental processes (MEIS1,
MEOX1 and FOXA1). Bc induced also known RA target genes
(TGM2, Mucin3A, Keratins, Cadherin1, RARb, MEOX1,
FOXA1). There was a high overlap between genes regulated
by bc and apocarotenals.
In summary, apocarotenals, as well as bc, increased the
expression of numerous RA target genes. Apocarotenals pro-
moted, rather than inhibited retinoid signaling in BEAS-2B cells.
Beta-carotene beadlets do not cause
changes in RARbeta, RARalpha
and PCNA expression nor
in histology in ferret lungs
A. Wyss, V. Elste, A. Kliemant, W. Cohn, U. Hoeller,
F. Ringenbach, G. Riss, E. Wolz, D. Wolff, J. Bausch,
R. Goralczyk
R&D Human Nutrition and Health, DSM Nutritional Products,
Kaiseraugst, Switzerland, Bundesamt für Verbraucherschutz und
Lebensmittelsicherheit (BVL), Berlin, Germany, Bundesinstitut
für Risikobewertung (BfR), Berlin, Germany
Recently it was reported that high dose oral gavage of crys-
talline unstabilized beta-carotene in oil to ferrets caused lung
metaplasia even in the absence of tobacco smoke exposure.
Our goal was to investigate whether stabilized beta-carotene
beadlets supplemented via diet would also lead to such adver-
se effects. Beta-carotene beadlets at 2 mg or 10 mg/kg BW/d
were mixed to the ferret chow and given to 4 ferrets per gro-
up as a daily bolus over 6 weeks. Controls received placebo
beadlets. Beta-carotene and vitamin A metabolites were ana-
lyzed in plasma, lung and liver. With quantitative Western blots
we estimated the expression levels of the nuclear hormone
receptors RARalpha and RARbeta, as well as the proliferating
cell nuclear antigen (PCNA) in the lung. Histological evaluation
was performed on paraformaldehyde fixed hematoxylin-eosin
stained sections and after anti-pancytokeratin immunohisto-
chemistry. We observed a dose dependent increase of beta-
-carotene concentrations in plasma, lung and liver. All vitamin A
metabolites including retinylesters and retinoic acid remained
unchanged in plasma, as well as in liver and lung. No apocaro-
tenals were detected in either tissue. The histopathological
examination of the lungs did not show any signs of squamous
metaplasia or other pathologies. Only spontaneous findings like
infiltration of lymphoid cells or alveolitis were observed. The
expression level of RARalpha and RARbeta in lung was similar
in all 3 groups (control, 2 mg beta-carotene/day and 10 mg/
/beta-carotene/day). The difference of PCNA expression among
the 3 groups was not statistical significant.In conclusion, our study
did not reveal any molecular or histological changes after 6 weeks
of high dose stable beta-carotene beadlet supplementation.
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Effects of oral beta-carotene
supplementation on cell cycle
markers in the lungs of ferrets
M.A. Fuster, C. Picó, P. Oliver, J. Sánchez, A. Palou
Laboratorio de Biología Molecular, Nutrición y Biotecnología,
Departamento de Biología Fundamental y Ciencias de la Salud,
Universitat de les Illes Balears, Palma de Mallorca, Spain
Epidemiological studies have demonstrated that people that
eat more fruits and vegetables (which are rich in carotenoids)
and people having higher serum beta-carotene levels have
a lower risk of cancer, particularly lung cancer. Beta-carotene
may exert a protective role because of its antioxidant activity
and/or because of its activity as a precursor of retinoic acid.
However, the two main human intervention studies using
20–30 mg daily doses of beta-carotene supplementation reve-
aled an increased risk of lung cancer among smokers and asbe-
stos workers. Previous studies carried out in the ferret, which
appears as an appropriate animal model for use in mimicking
the conditions of human beta-carotene intervention studies,
have reported a mechanistic explanation of the apparent para-
doxical effects of beta-carotene on lung cancer, and that its
effects could be related to dose: a pharmacological dose of
beta-carotene (2.4 mg/kg body weight/day) lead to squamous
metaplasia, a pre-cancerous lesion in the lung, and increases
the expression of some proto-oncogenes. However, a physio-
logical dose of beta-carotene (0.43 mg/kg body weight/day)
did not show these effects, but even provided mild protection
again squamous metaplasia in smoke-exposed ferrets. Here,
we treated ferrets with two concentrations of oral beta-caro-
tene (0.8 and 3.2 mg/kg body weight/day) for 6 months. Beta-
carotene was provided by DSM Nutritional Products as a wa-
ter soluble formulation (beadlets) containing 0.1% beta-caro-
tene crystalline, 0.015% DL-alpha-tocopherol, 0.04% ascor-
byl palmitate, 0.04% corn oil, 0.15% fish gelatine, 0.34% su-
crose and 0.315% corn starch. We analysed protein levels of
activator protein 1 (c-Jun and c-Fos), c-Myc, cyclin D1, prolife-
rating cellular nuclear antigen (PCNA), and retinoic acid re-
ceptor beta (RAR-beta) in lung samples by western blot to test
the hypothesis that coordinated effects of beta-carotene on
RAR receptors and oncogene expression may explain the ef-
fects of beta-carotene. Results show no apparently detrimen-
tal effects of beta-carotene on lung cell proliferation and su-
ggest that, in addition to the dose, the formulation (e.g. the
presence of alpha-tocopherol or other antioxidant compounds)
may be important in determining the pro- or anti-carcinogenic
effects of beta-carotene.
Beta-carotene stability and uptake
by human lung bronchial epithelial
cells depending on delivery vehicle
A.M. Rodriguez, S. Sastre, J. Ribot, A. Palou
Fundamental Biology and Health Sciences, University of the
Balearic Islands, Palma de Mallorca, Spain
Beta-carotene (BC) has aroused interest about its possible
protective or pro-carcinogenic role in lung cancer and cell cul-
ture systems are important to evaluate it. Nevertheless, the
delivery of BC to cells is difficult due to its hydrophobicity.
Different vehicles have been used. Ethanol, liposomes or
mixed micelles present problems of insolubility, stability or poor
uptake by the cells. Tetrahydrofuran (THF) has been widely
used, but it can be toxic and associated with enhancement of
tumour formation. Human lipoproteins or BC enriched steer
serum are efficient and more physiological vehicles, but not
practical. Water dispersible beadlets containing BC have been
used as an alternative and produce the greatest accumulation
of BC in cells when compared to above vehicles, but other
beadlet components (alpha-tocopherol, corn oil, etc) could al-
ter the results. Dimethylsulfoxide (DMSO) could be an alter-
native since it has low toxicity and it rapidly penetrates across
biologic membranes, allowing enhanced penetration of sub-
stances accompanying it. We aimed to characterize an appro-
priate model for delivering all-trans-BC to lung cells in culture.
We administered all-trans-BC 5 microM to BEAS-2B cells using
beadlets or DMSO, and medium and cell samples were taken
at different times. All-trans-BC reached the same levels in the
medium (about 3.5 microM) either in beadlets or in DMSO,
and, with beadlets, 13-cis-BC was also detected. However the
amount of all-trans-BC taken up by the cells was almost the
triple when delivered by DMSO compared to beadlets. With
both vehicles, intracellular all-trans-BC levels reached its ma-
ximum after 24 hours of treatment, and these levels remained
the same after 72 hours. The 9-cis and 13-cis forms of BC, as
well as other oxidized metabolites, were also detected inside
the cells; although their proportion was quite small respect to
all-trans-BC, especially when using DMSO. Lastly, a LDH
assay showed no toxicity of beadlets, DMSO or BC itself. In
conclusion, DMSO seems the most appropriate vehicle for de-
livering BC to lung cells in vitro, in terms of BC taken up, stabi-
lity and low formation of derivatives, allowing analysing the
effects of BC itself and minimizing interferences from derivati-
ves or other components of the vehicle.
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Comparison of influence of
beta-carotene on EPC and HUVEC
B. Kieć-Wilk1, A. Polus1, J. Grzybowska1,
M. Mikołajczyk1, J. Hartwich1, T. Langmann2,
G. Schmitz2, A. Dembińska-Kieć1
1Department of Clinical Biochemistry Collegium Medicum,
Jagiellonian University, Kraków, Poland, 2Department of Clinical
Chemistry and Laboratory Diagnostics, University Hospital
Regensburg, Germany
Either endothelial cells covering the inner site of a vessel
as well as circulating progenitor cells originating from the bone
marrow or other organs may serve as source of endothelial
cells for angiogenesis in an adult organism. Beside the growth
factors (such as: VEGF, bFGF, TGFbeta, PDGF) or cell/matrix
(integrins), cell/cell (VE cadherins, catenins, endoglins, ephrins
its receptors and Jagged/Notch pathway) as well the nutrition-
related compounds could regulate the most important steps
of angiogenesis like proliferation, migration and differentiation.
In our experiments we wanted to investigate regulatory influ-
ence of compounds from daily diet such as fatty acids and beta-
carotene on gene expression, proliferation, migration and di-
fferentiation on endothelial progenitor cells (EPC) in compari-
son to early differentiated endothelial cells (HUVEC).
Material and methods: Primary cultures of human endo-
thelial cells (HUVEC) were isolated from human umbilical vein
using collagenase digestion method and were grown in EBM
medium with supplement and antibiotics. AC133+ cells were
isolated from human cord blood using magnetic microbits (Mil-
teny Biotech) and incubated in EBM medium (with supplement
and antibiotics) and with SCF (100 ng/ml) and VEGF (50 ng/ml)
six days to obtain endothelial progenitor cells (EPC). Influence
of the 24-hour incubation with beta-carotene alone or with
arachidonic acid (AA) on the gene expression was measured
using oligonucleotide chips (Affymetrix), confirmed by Real-
-Time PCR and flow-cytometry. Analysis in promotor sequence
transcription factor binding sites of regulated genes help us in
searching of activated pathways in cells by investigated factors.
The cytotoxic effect was checked by estimation of LDH level in
tissue medium. Beta-carotene uptake analysis was performed
using HPLC. The effect on cell proliferation (rate of DNA syn-
thesis) was  measured by BrdU incorporation. Apoptosis was
investigated using Apo Fluor TM Green Kit (all caspases activity
detection). Chemotaxis was performed using Boyden Chamber
System (Becton Dickinson). Angiogenic potency was investiga-
ted by the angiogenesis assay in the in vitro and in vivo model.
Results: Beta-carotene was uptaked by EPC and HUVEC was
potentiated by arachidonic acid. AA as well BC significantly po-
tentiated basal chemotaxis of EPC and HUVEC cells In spite of
microarray-based analysis of gene expression arguing for sti-
mulation of angiogenesis no influence of this compounds on
proliferation and apoptosis as well as any influence on the tu-
bule formation in the 3D model in vitro were observed. Conc-
lusion. We have demonstrated that BC-in the physiological ran-
ge of concentrations found in human blood is a potent activa-
tor of chemotaxis of early endothelial progenitor cells and HU-
VEC what is accompanied by the change in the expression of
genes mediating cell adhesion and homing, but not activate the
final markers of the endothelial differentiation.
Supported by the EU F5 DLARFID QLTR-2001-00183 and
STEC QLK3-CT-2002-30307 projects. The authors thank the DSM
Nutritional Products for support.
Proangiogenic activity
of beta-carotene is coupled with
the activation of endothelial cell
chemotaxis
A. Polus1, J. Grzybowska1, M. Mikołajczyk1,
B. Kieć-Wilk1, J. Hartwich1, T. Langmann2,
G. Schmitz2, A. Dembińska-Kieć1
1Department of Clinical Biochemistry Collegium Medicum,
Jagiellonian University, Kraków, Poland, 2Department of Clinical
Chemistry and Laboratory Diagnostics, University Hospital,
Regensburg, Germany
Endothelial cells play an important role in angiogenesis (for-
mation of new vessels from preexisting ones) which is essen-
tial for organogenesis, tissue remodeling but also inflammatory
response, carcinogenesis in all periods of our life. Carotenoids
present in human tissues function as free radical scavengers,
immunomodulators, or some being the substrate for retinol
(Vitamin A) and retinoic acid (RA) are regulators of cell fate
and differentiation. The study was undertaken to define the
direct effects of beta-carotene on endothelial cells in terms of
angiogenic activity and regulation of gene expression.
Material and methods: Primary cultures of human endo-
thelial cells (HUVEC) were isolated from human umbilical vein
using collagenase digestion method and were grown in EBM
medium with supplement and antibiotics. Beta-carotene uptake
analysis was performed using HPLC. Influence of the 24-hour
incubation with beta-carotene alone or with arachidonic acid
(AA) addition on the gene expression was measured using
oligonucleotide chips (Affymetrix), and confirmed by Real-Time
PCR. Analysis in promotor sequence transcription factor bin-
ding sites of regulated genes help us in searching of activated
pathways in cells by investigated factors. The effect on cell pro-
liferation (rate of DNA synthesis) was measured by BrdU in-
corporation. Apoptosis was investigated using Apo Fluor TM
Green Kit (all caspases activity detection). Chemotaxis was per-
formed using Boyden Chamber System (Becton Dickinson).
Angiogenic potency was investigated by the tubule formation
assay in the in vitro 3D matrigel model.
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Results: Beta-carotene in the non-toxic concentrations
(up to 3 mM) had no detectable effect on HUVECs proliferation
or apoptosis, despite significant influence on the expression
patterns of pro- and anti-apoptotic genes. However, beta-caro-
tene did not change the tubulogenic activity of HUVEC in the
in vitro angiogenesis model, potently accelerated the develop-
ment of microcapillaries as well as migration of endothelial cells
in matrigel plug injected subcutaneously to mice. Potent acti-
vation of endothelial cell migration in the in vitro model of che-
motaxis was observed. The microarray data analysis revealed
that the genes involved in cell/cell; cell /matrix adhesion; ma-
trix reorganization; activation of chemotaxis; the G-protein
regulated intracellular signaling as well as genes involved in the
rapid remodeling of the actin cytoskeleton were the most
affected by BC genes in HUVEC.
Conclusion: Beta-carotene in the physiological concentra-
tion range stimulates early steps of angiogenic activity of endo-
thelial cells by activation of cellular migration as well as matrix
reorganization and decrease of cell adhesion.
The authors thank the DSM Nutritional Products for support.
Supported by the EU F5 DLARFID QLTR-2001-00183 and
STEC QLK3-CT-2002-30307 projects.
Influence of squalene treatment
on signal transduction
O. Bogdanova, L. Ostapchenko
Biochemistry Department, Taras Shevchenko Kyiv National
University, Kyiv, Ukraine
Squalene, an intermediate metabolite in the synthesis of
cholesterol, is established now as natural immunostimulating
drug with wound healing activity and radiation protective
action. It is known that survival of squalene-fed animals subjec-
ted to whole body irradiation in lethal doses was significantly
prolonged compared with control-fed ones. This effect of squa-
lene treatment may be explained by confirmation its immuno-
potentiating radioprotective influence upon molecular mecha-
nisms regulating lymphoid cells functioning.To estimate the
effect of squalene administration on signal transduction under
conditions of different pathological states, the levels of protein
tyrosine phosphatase activities in membrane fractions and cy-
tosol of rat spleen and thymus lymphocytes under conditions
of aspirin induced stomach ulcer development and whole body
irradiation in different doses were investigated. The enzymes
of dephosphorylation play myriad roles in regulation of signal
transduction in lymphoid cells. In addition, since the neoplastic
transformation of cells and apoptosis development is often
accompanied by changes in the state of phosphorylation of ty-
rosine residues in proteins, the catalytic function of protein ty-
rosine phosphatases may be a crucial factor in cell differentia-
tion, growth and function regulation. It was shown that the
squalene administration caused increasing and normalizing
of dephosphorylating abilities of protein tyrosine phosphatases,
which were failed in rats with utilizing ulcer.these enzymes.
The extension of administration term increased these effects.
It was established diverse dose-dependent effects of  whole
body irradiation on levels of protein tyrosine phosphatase acti-
vities. The maximal values of fermentative activities were obse-
rved in dose of 0.5 Gy in the most of examined origins. In agre-
ement with the proposes mechanism it was demonstrated that
supplementation of squalene to rats has resulted in some shift
of maximal values of protein tyrosine phosphatase activities to-
wards higher doses of irradiation in spleen lymphocytes but not
in thymus ones. Taken together, the data favor the hypothesis
that the squalene treatment potentially increases lymphatic sys-
tem resistance to damaging action of development such patho-
logical states as stomach ulcer and whole body irradiation.
Influence of PPARg agonists on
endothelial cells differentiation and
on bFGF and VEGF-dependent
tubulogenesis
J. Grzybowska1, 3, B. Kieć-Wilk1, A. Polus1,
E. Piątkowska1, K. Kristiansen2, A. Dembińska-Kieć1
1Department of Clinical Biochemistry, The Jagiellonian University
Medical College, Kraków, Poland, 2Department of Biochemistry
and Molecular Biology, University of Southern Denmark, Odense,
Denmark, 3Postgraduate School of Molecular Medicine Medical
University of Warsaw, Warsaw, Poland
Background and objective: The Jagged-Notch system plays
a crucial role in endothelial cell differentiation and angiogene-
sis. High Notch4 expression characterizes proliferating endo-
thelial cells, and Jagged/Notch interaction may regulate the
vessel wall cell differentiation. VEGF, a potent stimulator of
proliferation, induces the expression of Jagged 1 in endothelial
cells whereas bFGF, a known stimulator of differentiation,
down-regulates expression of Notch and Jagged.
The fatty acid and its derivatives activated peroxisome pro-
liferation-activated receptors (PPARs) are important regulators
of cellular growth and maturation, including endothelial cell
differentiation and angiogenesis. In previous work we demon-
strated that administration of the PPARg agonist: ciglitazone
down-regulates expression of Jagged1 and Notch4 in endothe-
lial cells and inhibits tubulogenesis and branching of tubules in
the 3D matrigel model of angiogenesis. Present work was aimed
at elucidating the signaling pathways involved in the PPARg-
-dependent inhibition of HUVECs proliferation, differentiation and
in regulation of Jagged1/Notch4 expression in endothelial cells in
response to treatment with VEGF, bFGF and PPARg agonists.
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Material and methods: HUVEC (70% of confluence) were
stimulated with VEGF, bFGF or PPARg activators for 24 hours.
Total RNA was isolated and used for real-time RT- PCR analy-
ses (DNA Engine Opticon) to determine Jagged-1 and Notch-4
gene expression. Studies of cell differentiation were perfor-
med using the 3D matrigel. tubulogenesis model system.
The influence of proangiogenic VEGF (10 ng/ml), and bFGF
(10 ng/ml) or antiangiogenic ciglitasone (PPARg agonist at 1 to
10 mM) factors on Jagged1/ Notch4 protein expression and the
phosphorylation-dependent activation of protein kinases invo-
lved in intracellular signaling pathways were detected by We-
stern blot analysis. To determine the role of selected intracel-
lular signaling pathways in differentiation, proliferation and Ja-
gged-1/Notch-4 expression the coincubation with the specific
inhibitors of p38MAPK (SB202190 at 10 mM), PI3K (LY 294002
at 10 mM) and p42/44 MAPK (U0126 10 mM) were used.
Results and conclusions: Incubation of HUVECs with PPARg
agonist affected both proliferation as well as differentiation of
these cells. We notably found that bFGF and ciglitazone (PPARg
agonist), unlike VEGF, down-regulates Jagged-1 and Notch-4
expression. This inhibitory effect required p38 MAPK and Akt
signaling pathway. Using the specific kinase inhibitors and the
3D tubulogenesis model we were able for the first time de-
monstrated that p38MAPK plays a key role in antyangiogenic
activity of ciglitazone, the PPARg agonist.
The authors thank the DSM Nutritional Products for support.
Supported by the EU F5 DLARFID QLTR-2001-00183.
The effect of beta-carotene on
differentiation, cytotoxicity,
apoptosis and proliferative potential
on the three human acute leukemia
cell lines
T. Sacha, M. Zawada, J. Hartwich, Z. Lach, A. Polus,
M. Szostek, E. Zdziłowska, M. Libura, M. Bodzioch,
A. Dembińska-Kieć, R. Goralczyk, K. Wertz, G. Riss,
C. Moehle, T. Langmann, G. Schmitz, A.B. Skotnicki
Chair and Department of Haematology, Jagiellonian University
Medical College, Kraków, Poland, Department of Clinical
Biochemistry Jagiellonian University Medical College, Kraków,
Poland, DSM Nutritional Products R&D, Human Nutrition and
Health, Basel, Switzerland, Department of Clinical Chemistry,
Laboratory Medicine and Transfusiology, University of
Regensburg, Regensburg, Germany
The influence of beta-carotene (BC) and its derivatives on
differentiation, proliferation and apoptosis in three human acute
leukemia cell lines was studied. We investigated: (i) the cellular
uptake of BC, (ii) the cytotoxicity, (iii) the effect on cell cycle
progression and/or apoptosis. The dose- and time dependent
pattern of cellular BC uptake in all studied cell lines was seen.
We did not observe any cytotoxic effect of BC and ATRA in
chosen concentrations.  There was only limited effect of BC
on gene expression. The microarrray analysis of U-937 cell line
exposed to BC for 72 hours showed an increased expression
of BAX gene. This finding was confirmed by real-time Q-PCR
analysis, and supported by a flow cytometry apoptosis tests.
We did not observe any influence of studied components on
cellular proliferation. The induction of differentiation after in-
cubation with ATRA in HL-60 cells was noted. The induction
of cellular apoptosis by BC was seen in all studied cell lines.
We demonstrated that BC used in the concentrations achieva-
ble in vivo does not affect the proliferation and differentiation
process of studied leukemic cell lines, but can influence and
enhance the apoptosis by modulating the expression
of the regulatory genes.
The authors thank the DSM Nutritional Products for support.
Supported by the EU F5 DLARFID QLTR-2001-00183.
The potential of beta-carotene to
influence the cell fate through the
induction or inhibition of apoptosis
M. Bodzioch1, A. Dembińska-Kieć2, J. Hartwich2,
K. Łapicka-Bodzioch 2, J. Grzybowska2, A. Polus1,
I. Wybrańska1, A. Banaś1, J. Dulińska2, D. Gil1, P. Laidler2,
W. Placha2, M. Zawada2, A. Balana-Nowak3,
T. Sacha3, B. Kieć-Wilk3, A.B. Skotnicki1,
C. Moehle4, T. Langmann4, G. Schmitz4
1Department of Clinical Biochemistry, 2Department of Medical
Chemistry, 3Department of Hematology, Collegium Medicum,
Jagiellonian University, Kraków, Poland, 4Department of Clinical
Chemistry, Laboratory Medicine and Transfusiology, University
of Regensburg, Regensburg, Germany
Background: Beta-carotene is rich in human diet both from
natural agricultural products and as common food additive.
However, some intervention trials have shown that it might
trigger or promote cancerogenesis, especially lung cancer.
Objective: To assess the effects of beta-carotene on global
gene expression in human models of neoplastic and normal
actively proliferating cells.
Material and methods: microarray analysis of gene expres-
sion patterns in response to beta-carotene in melanoma A375
and myelomonocytic leukemia U937 cell lines compared to
cultured human umbilical vein endothelial cells (HUVECs) fo-
llowed by real-time quantitative PCR and biological tests for
apoptosis (caspase detection and TUNEL).
Results: The experiments with the Affymetrix U133A chips
suggested the proapoptotic BAX as a common beta-carotene
responder in all three cell lines studied. It was upregulated in
both A375 and U937 cells, and downregulated in HUVECs.
The microarray findings were confirmed by quantitative real-
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-time PCR analysis, which also demonstrated concordant chan-
ges in other pro- (BAD, BAK1, BNIP1, and BCLXS) and anti-
apoptotic (BCLXL, and BCL2 isoforms 1 and 2) genes. Tests for
apoptosis produced results consistent with gene expression
patterns observed in U937 cells and HUVECs, though there
was no indication of the predicted induction of apoptosis in
the melanoma A375 cells.
Conclusions: Beta-carotene influenced the expression
of pro- and antiapoptotic genes in actively proliferating cells.
Proapoptotic expression patterns seen in neoplastic cells in re-
sponse to beta-carotene may (U937) or may not (A375) result
in the induction of apoptosis.
This work was supported by the EU Project QLK1-CT-2001-
-00183 - DLARFID (Dietary Lipids as Risk Factors in Development.
Mechanistic Issues).
The authors thank the DSM Nutritional Products for support.
Effect of catechin and epicatechin on
pyruvate dehydrogenase kinase
activity in primary culture of rats
hepatocytes
M. Tyszka-Czochara, M. Knapik-Czajka,
A. Goździalska, J. Jaśkiewicz
Zakład Analityki Biochemicznej, Wydział Farmaceutyczny
z Oddziałem Analityki Biochemicznej Collegium Medicum
Uniwersytetu Jagiellońskiego
Pyruvate Dehydrogenase Complex (PDH) plays crucial role
in Randle cycle, which describes interrelationships between car-
bohydrate and lipid metabolism in mammals. PDH catalyses
irreversible reaction of decarboxylation of pyruvate to acetylCoA.
PDH Complex contains three enzymes, E1 (Pyruvate De-
hydrogenase), E2 (Dihydrolipoamide Acetylotransferase) and
E3 (Dihydrolipoamide Dehydrogenase) and two regulatory
enzymes Pyruvate Dehydrogenase Kinase (PDK) and Pyruvate
Dehydrogenase Phosphatase (PDP). PDH complex is mainly
regulated by covalent modification. A specific PDH kinase
(PDK) catalyses phosphorylation of PDH which results in inac-
tivation whereas a specific PDH phosphatase (PDP) catalyses
dephosphorylation and reactivation of PDH complex. PDK is
a major factor influencing PDH activity.
It was established that PDK activity is modified by various
groups of xenobiotics. One of them are catechins, commonly
known plant secondary metabolites ubiquitous in human diet.
Current interest of biological activities of catechins is due to
their antioxidant properties. It is belived that numerous cate-
chins also improve carbohydrate and lipid metabolism in mam-
mals. Very few studies on influence of catechins on key meta-
bolic enzymes activities were performed. Furthermore, the
mechanism of the action of these compounds on molecular
level is still unclear. The effect of catechins on PDH activity has
not been studied yet.
This study investigated the effect of selected catechins:
catechine and epicatechine on PDK activity in primary rat’s he-
patocytes culture. Liver cells were isolated from male rats and
incubated with addition of different doses of catechins. Control
hepatocytes were cultured under the same conditions without
any catechins. After 24 hours of incubation all cultures were
harvested and mitochondria were isolated. In mitochondrial pro-
tein extracts PDK activity as well as expression of PDK-2 isoen-
zyme were assayed. PDK activity was assayed spectrophoto-
metrically by the rate of ATP-dependent inactivation of PDH
complex was calculated as the first-order rate constant. Expre-
ssion of PDK-2 protein was assayed by Western blott analysis.
All tested catechines affected PDK activity and expression
of enzyme protein. Adverse correlation between PDK activity
and concentration of catechins was demonstrated. All tested
catechins remarkably decreased PDK activity and PDK-2 pro-
tein amount comparing with control group. The degree of re-
duction of PDK activity strongly depended on the dose of par-
ticular catechins. In conclusion catechins affecting PDK activity
modify PDH complex activity and in consequence exert an
effect on glucose and lipid metabolism.
Effect of polyphenols and etanol
on pyruvate dehydrogenase kinase
activity in primary culture of rats
hepatocytes
M. Tyszka-Czochara, M. Knapik-Czajka,
A. Goździalska, J. Jaśkiewicz
Zakład Analityki Biochemicznej, Wydział Farmaceutyczny
z Oddziałem Analityki Biochemicznej Collegium Medicum
Uniwersytetu Jagiellońskiego
Pyruvate Dehydrogenase Complex (PDH) catalyses irre-
versible reaction of decarboxylation of pyruvate to acetylCoA.
PDH complex is a regulatory point of Randle cycle and there-
fore plays a key role of the overall glucose and lipid disposal in
mammals.
PDH complex is mainly regulated by covalent modifica-
tion. A specific PDH kinase (PDK) inactivate PDH complex by
phosphorylation of specific serine residues whereas a specific
PDH phosphatase (PDP) exerts adverse effect. PDK is a major
factor influencing PDH activity.
The activity of PDK is regulated in short term by mitochon-
drial NADH/NAD+ and acetylCoA/CoA ratios as well as ATP/
/ADP ratio. Besides, the activity of PDK is modified in long
term by nutritional factors includind red wine polyphenols and
ethanol.
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This study investigated the effect of polyphenols such as
caffeic acid + catechine and ethanol on PDK activity in prima-
ry rat’s hepatocytes culture. Liver cells were isolated from male
rats. Primary cultures of isolated hepatocytes were incubated
with addition of established doses of polyphenols or ethanol or
with the mixture of polyphenols and ethanol.  Control hepato-
cytes were cultured under the same conditions without any
additives. After 24 hours of incubation all cultures were harve-
sted and mitochondria were isolated. In mitochondrial protein
extract PDK activity as well as expression of PDK-2 isoenzyme
were assayed. PDK activity was assayed spectrophotometri-
cally by the rate of ATP-dependent inactivation of PDH com-
plex and calculated as the first-order rate constant. Expression
of PDK-2 protein was assayed by Western blott analysis.
It was established that polyphenols caused a reduction in
PDK activity as well as a reduction in PDK-2 isoenzyme prote-
in amounts comparing with control group. On the contrary,
ethanol increased PDK activity and PDK-2 isoenzyme protein
amount, opposite to polyphenols.
To sum up red wine polyphenols may regulate activity
of carbohydrate as well as lipid metabolism and change the
influence of ethanol on PDH complex activity in mammals.
UCP1 is expressed in both white
and brown adipose tissues of ferrets
and is down-regulated after six
month daily oral beta-carotene
supplementation
 J. Sánchez, M.A. Fuster, P. Oliver, C. Picó, A. Palou
Laboratorio de Biología Molecular, Nutrición y Biotecnología,
Departamento de Biología Fundamental y Ciencias de la Salud,
Universitat de les Illes Balears, Palma de Mallorca, Spain
UCP1 is expressed in both white and brown adipose tissu-
es of ferrets and is down-regulated after six month daily oral
beta-carotene supplementation. It is known that nutrients are
able to affect adipogenesis and/or may have pro-thermogenic
properties that can be useful to help control body weight or
the medical complications of obesity. Beta-carotene, a vitamin
A precursor, could be considered among the different factors
influencing energy balance, since in recent years, a growing
body of evidence shows that vitamin A derivatives (retinoids)
are involved in the control of biological aspects, including adi-
posity and energy expenditure mechanisms. Here we studied
the effects of six month daily oral administration of different
doses of supplemental beta-carotene (0.8 mg/kg/day or 3.2 mg/
/kg/day) in ferrets on body weight and the size of body fat de-
pots and on UCP1 levels (Western blot) in white and brown
adipose tissue (WAT and BAT, respectively). Animals that re-
ceived the high dose of beta-carotene gained more weight than
control animals and body weigh at the end of the treatment
was 14% higher than controls (p < 0.05). No effect was seen
with the low dose. Food intake was not affected by beta-caro-
tene supplementation. The size of the subcutaneous inguinal
depot in animals treated with the high dose of beta-carotene
was significantly higher (p < 0.05) than that of animals treated
with the low dose and slightly higher than that of controls (19%
and 16% higher, respectively). Other depots, particularly go-
nadal and retroperitoneal WAT, were also slightly higher in
animals treated with the high dose of beta-carotene compared
with controls, while no apparent effect of beta-carotene was
found in the size of parametrial and mesenteric depots. UCP1
was significantly produced in the interscapular BAT and also in
the inguinal and retroperitonal WAT depots. Beta-carotene
treatment reduced UCP1 protein levels in these depots. In both
WAT depots, the decrease was already significant with the low
dose of beta-carotene;  in BAT the effect was significant with
the highest dose. In conclusion, six months of daily oral supple-
mentation with beta-carotene in the ferret produced an incre-
ase in body weight and in the size of the inguinal fat depot and
decreased UCP1 levels in brown and white adipose tissues.
Modulation of resistin expression
by retinoic acid and vitamin A status
F. Felipe, J. Ribot, M.L. Bonet, A. Palou
Laboratory of Molecular Biology, Nutrition and Biotechnology,
Universitat de les Illes Balears, Palma de Mallorca, Spain
Aim: Adipocytes secrete many bioactive compounds,
among them resistin, a protein that appears to inhibit adipocy-
te differentiation and to act as a systemic insulin resistance fac-
tor. As retinoic acid (RA), vitamin A regulates transcription of
target genes (mainly through activation of the retinoid recep-
tors, RARs and RXRs) and impacts on different aspects of the
biology of adipose tissues. Our aim was to assess the impact of
RA and vitamin A status on resistin expression, gaining insight
into the mechanistic aspects and into the functional relevance
of this regulation, in terms of changes of glucose tolerance.
Material and methods: Resistin expression was measured
in 3T3-L1 adipocytes and primary cultures of brown adipocy-
tes treated with retinoids, and in fat depots and serum of mice
acutely treated with RA or chronically fed vitamin A-supple-
mented diets. Blood parameters and glucose tolerance tests
were also conducted.
Results: RA reduced resistin mRNA levels in the adipocyte
cell models. The effect was time and dose-dependent, was fo-
llowed by a reduced secretion of resistin and was reproduced
by selective agonists of both RARs and RXRs. RA administra-
tion to normal mice resulted in reduced resistin mRNA levels
in brown and white adipose tissues, reduced circulating resis-
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tin levels, reduced body weight and adiposity and improved
glucose tolerance. Resistin expression was also down-regula-
ted after dietary vitamin A supplementation in mice.
Conclusions: RA is an inhibitory signal for resistin expre-
ssion in adipocytes. Our results are compatible with resistin
acting as an insulin resistance factor, but improved glucose to-
lerance may reflect other effects of RA-treatment, particularly
its weigh-reducing effect.  The possible relationship among vita-
min A status, insulin sensitivity and adipokine expression dese-
rves further studies.
Retinoic acid treatment induces
brown fat cell features in murine
white adipose tissues
J. Mercader, F. Felipe, J. Ribot, A. Palou, M.L. Bonet
Laboratory of Molecular Biology, Nutrition and Biotechnology,
Universitat de les Illes Balears, Palma de Mallorca, Spain
Aim: Inefficient oxidation of fuel molecules may contribute
to reduced adiposity and is a metabolic feature of brown adi-
pose tissue (BAT), thanks to the specific expression of un-
coupling protein 1 (UCP1). Retinoic acid (RA), the carboxylic
form of vitamin A, signals transcriptional activation of the UCP1
gene in brown adipocytes. The aim of this work was to analyse
the effects of RA-treatment on the expression of UCP1,
PGC1alpha (a transcriptional coactivator linked to thermoge-
nesis), PPARalpha (a transcription factor that activates the
expression of fatty acid oxidation enzymes) and CPT1 (a target
gene of PPARalpha) in murine WAT depots.
Material and methods: The mRNA levels of transcripts
of interest were analysed by RT-PCR in adipose tissue depots
of adult NMRI male mice treated with vehicle (olive oil) or all-
trans RA (at 10, 50 or 100 mg/kg/day, during the 4 days prece-
ding sacrifice). Body weight, fat pad weight and serum non-
esterified fatty acids (NEFA) were also determined.
Results: Treatment with RA reduced the weight of all fat
pads without a concomitant increase of circulating NEFA le-
vels. In retroperitoneal WAT, RA treatment stimulated UCP1
mRNA, UCP1 protein, PGC1alpha mRNA and PPARalpha
mRNA expression. A trend to increased expression of UCP1,
CPT1 and PPARalpha mRNA levels was also apparent in ingu-
inal WAT of RA-treated animals.
Conclusion: Our results underscore the idea of adipose
tissue plasticity, and suggest that RA may favour to some extent
the acquisition of BAT-like properties in WAT depots, promoting
the mobilization of WAT fat reserves and the in situ oxidation
of the fatty acids released, coupled to the generation of heat.
Effect of PPAR gamma agonist and
high fat diet on the content and
composition of ceramides and
sphingomielines in the skeletal
muscle of the rat
M. Żendzian-Piotrowska, P. Zabielski,
M. Baranowski, J. Górski
Department of Physiology, Medical University of Bialystok,
Bialystok, Poland
Effect of PPAR  gamma agonist and high fat diet on
the  content and composition of ceramides and sphingomielines
in the skeletal muscle of the rat
The sphingomyelin signaling pathway is an ubiquitous, evo-
lutionarily conserved signalling system. Ceramide which serves
as the second messenger in this pathway, is generated from
sphingomyelin or by de novo synthesis. However, there are
almost no data on metabolism of the ceramide in the skeletal
muscle. The aim of the study was to examine the effects
of PPAR gamma ligand-pioglitazone on the content and com-
position of ceramides and sphingomyelins in the skeletal musc-
les. The experiments were carried out on two groups of male
Wistar rats, 200–220 grams of  body weight. One group was
fed with  a standard diet for rodents, and another group was
fed with high fat diet ( 48% of fat) for 3 weeks. Each group was
divided into two subgroups: 1 — control, 2 — treated with
pioglitazone (agonist of PPAR gamma). Pioglitazone were ad-
ministered by oral gavage with a vehicle in a dose of 3 mg/kg
for 14 days. Samples of the soleus, red and white gastrocne-
mius were taken, frozen in liquid nitrogen and pulverized. Li-
pids were then extracted with chloroform/methanol (2:1 v/v).
Sphingomyelin (SM) and ceramide (CER) were then isolated
by means of thin layer chromatography. Lipid bands containing
SM and CER were scraped off the plates, methylated and  par-
ticular fatty acids content were analyzed using gas-liquid chro-
matography. Eleven different ceramides and sphingomyelins
were identified and quantified. They contained the following
fatty acid residues: myristic, palmitic, palmitoleic, stearic, oleic,
linoleic, arachidonic, nervonic, arachidic, docosapentaenoic and
behenic. Total level of analyzed lipids was calculated as sum
of individual fatty acids. It has been found that feeding with
high fat diet increased total level of SM and CER markedly in all
examined muscles. Piogltazone reduced total content of SM
and CER in all examined muscles. Both high fat and pioglitazo-
ne altered composition of SM and CER and the ratio of satura-
ted to unsaturated fatty acids. It is concluded that activity
of the sphingomyelin pathway  in the skeletal muscles is under
PPAR-gamma control.
47
Abstracts
www.angiologia.pl
The adiponectin level in patients
with familial obesity
M. Malczewska-Malec, Ł. Partyka,
I. Wybrańska, M. Szopa, I. Leszczyńska-Gołąbek,
A. Dembińska-Kieć
Department of Clinical Biochemistry, Collegium Medicum
of Jagiellonian University, Kraków, Poland
Low adiponectin level is associated with insulin resistance
and obesity. Decrease in the synthesis and/or secretion of adi-
ponectin from the adipose tissue is suggested to play a role in
the development of atherosclerosis.
The aim of our study was to estimate the link between
plasma adiponectin level and postprandial lipemia/glicaemia in
patients with familial obesity.
Material and methods: eighty patients from obese families
were examined. The measurement of BMI, WHR and the per-
cent of fat tissue was performed (Maltron BF-905). Serum adi-
ponectin, TG, FFA, glucose, insulin, leptin and vWF were de-
termined during oral lipid tolerance test (OLTT) and oral glu-
cose tolerance test (OGTT). Polymorphisms of the obesity
candidate-genes’: PPARgamma2, beta2AR, beta3 AR, LPL-H, D2R
were also considered as the metabolic determinants.
Results: In the group of 80 patients (43 women, 37 men)
the mean BMI was 33.4 kg/m2 (SD ± 7.3), percentage of body
fat was 35.2 (SD ± 18.8). The mean adiponectin level in all
subjects was 8.28 mg/ml (SD ± 4.9). The level of plasma adi-
ponectin negatively correlated with WHR (p < 0.05) and
the waist circumference (p < 0.05). Plasma adiponectin level
was significantly higher in women than in men and in lean subjects
compared to obese ones. Moreover men with lower adipo-
nectin demonstrated elevated von Willebrand levels. Signifi-
cant negative correlation between TG concentration and posi-
tive correlation between FFA concentration and plasma adi-
ponectin level was noticed during OLTT. Significantly dimini-
shed adiponectin level was observed in patients with increased
insulin and glucose concentration during OGTT. HOMA-IR was
increased in patients with low adiponectin concentration both
in women and men. No correlation was observed between
adiponectin plasma level and genes’ polymorphisms.
Conclusions: Glycemia/lipemia tolerance parameters are
impaired in obese patients with decreased adiponectin level.
Impaired postprandial FFA tolerance might be regarded as risk
factor of insulin resistance and endothelial dysfunction.
This work was supported by Ministry of Scientific Research
and Information technology grants 4P05D08424; 4P05D05319; 501/
/Pkl/113/L, 501/Kl/563/L, WŁ130/P/L.
The quest for metabolic syndrome
in the nutrigenetics era: beta
adrenergic gene polymorphisms
and weight lowering therapies
M. Szopa, M. Malczewska-Malec, Ł. Partyka,
I. Wybrańska, S. Niedbał, A. Dembińska-Kieć
Department of Clinical Biochemistry Collegium Medicum,
Jagiellonian University, Kraków, Poland
Nutrigenetics and nutrigenomics are promising multidisci-
plinary fields that focus on studying the interactions between
nutritional factors, genetic factors and health outcomes. Their
goal is to achieve more efficient individual dietary intervention
strategies aimed at preventing disease, improving quality of life
and achieving healthy aging. Many studies, using population-
based and intervention studies have found evidence for inte-
ractions between dietary factors, genetic variants and bioche-
mical markers of metabolic syndrome. Now, the characteriza-
tion of individuals who may respond better to one type of die-
tary recommendation than another begins.
The aim of this study was to investigate whether the
Gln27Glu polymorphism of the beta2 adrenoreceptor (BAR2)
gene contributes to differences in efficacy of weight lowering
therapies.
Material and methods: A total of 50 women (age: 32.08 ±
± 6.81) recruited from families with familiar trait of obesity
participated in the three month intervention study using diet
or diet and exercise programs. BAR2 genotype was determi-
ned  by polymerase chain reaction followed by ITA I digestion.
Anthropometric measurements (weight, height, body fat) and
biochemical measurements (serum level of cholesterol, trigly-
ceride, glucose, insulin, leptin) during OLTT and OGTT were
performed at the beginning and after therapies.
Results: The frequency of the Glu27 allele did not signifi-
cantly differ in the obese patients (58%) and lean controls
(68%). At the baseline of BMI, body weight, body fat or blood
lipid and glucose profiles, there was no significant difference in
obese with/without the Glu27 allele of the BAR2. The inte-
rvention with diet yielded  a triglyceryde reduction  and indu-
ced a significant difference in BMI (–6.31; –3.17), total chole-
sterol (–8.89; +1.75), HOMA (–17.34; +0.04) for women wi-
thout the Glu27 allele and with it, respectively. After diet and
physical training therapy significant lower values were found in
BMI, body fat % and leptin concentrations among obese ca-
rriers of the Glu27 allele. Women with the Glu27 allele showed
significant decrease of BMI (–8.3) and fat content (–17.83) after
therapy wit diet and physical training.
Thus, anthropometric and biochemical effects of weight-
lowering strategies are modulated by a BAR2 polymorphism.
Variability at the BAR2 gene is also associated with phenotype
of metabolic syndrome. This knowledge should lead to suc-
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cessful dietary recommendations partly based on genetic fac-
tors that may help to reduce metabolic syndrome risk more
efficiently than the current universal recommendations.
This work was supported by Ministry of Informatics and Science
grants 4P05D08424; 4P05D01016; 501/Pkl/113/L, 501//Kl/563/L,
WŁ130/P/L and NuGo (FP6-2002-FOOD 506360 NuGo” European
Nutrigenomics Organisation — Linking genomics, nutrition and
health research).
SNPs as determinants
of inter-individual variation
in beta-carotene/vitamin A
metabolism
W. Leung, C. Meplan, J. Hesketh, G. Lietz
University of Newcastle, Newcastle, United Kingdom
Beta-carotene is a major source of vitamin A in the diet.
Several important genes are involved in the metabolism and
absorption of beta-carotene. Beta-carotene 15, 15’; monoxy-
genase is the key enzyme involved in beta-carotene conver-
sion to vitamin A. Beta-carotene absorption and conversion to
vitamin A has been found to be highly variable between well
nourished healthy individuals. Within the Western population
50% have been classified as low responders to beta-carotene
(Hickenbottom et al. 2002). Using SNP detection, genotyping
and beta-carotene supplementation studies the aim is to de-
termine if the low responder trait is a result of genetic poly-
morphisms in key carotenoid cleavage enzymes.  Potential SNPs
in beta-carotene 15, 15’; monoxygenase  were detected by
dHPLC using PCR fragments derived from all 11 exons.  Seve-
ral SNPs were identified in beta-carotene 15, 15’; monoxyge-
nase though only SNPs result in amino acid changes confirmed
by direct sequencing. Although a correlation between these
SNPs and the low responder trait has yet to be made the fre-
quency of both SNPs are over 40% which corresponds with
the high percentage of low responders. The second phase of
the work will involve a beta-carotene supplementation trail in
healthy human volunteers that will correlate response to SNPs
identified in beta-carotene 15, 15’; monoxygenase.  This will
involve volunteers taking a single oral dose of  beta-carotene
with a fat rich meal  and the response measured 3 hours after
the meal.
Switching between physical and
chemical mechanism of ROS
quenching by carotenoids
J. Fiedor, R. Haessner, H. Scheer, L. Fiedor
Faculty of Biotechnology, Jagiellonian University, Kraków,
Poland, Department of Chemistry, TU Munich, Garching,
Germany, Department of Biology I-Botany, LMU, Munich,
Germany
Carotenoids are important natural antioxidants and pho-
toprotective compounds in plant and animal cells. In photo-
synthesis, apart from light-harvesting function they act as phy-
sical quenchers of (bacterio)chlorophyll excited triplet states
and of reactive oxygen species, such as singlet oxygen. They
might be also involved in chemical quenching when quenching
processes proceed further to cause chemical reactions with
reactive oxygen, yielding oxygenated derivatives of caroteno-
ids. We have recently shown that the physical quenching
of ROS by carotenoids can be replaced by chemical one due to
a simple change of solvent. In tetrapyrrole — photosensitised
reactions in methanol, all-trans beta-carotene (Car) acts only
as the physical quencher of singlet oxygen. A change of the
solvent into acetone, completely reroutes the reactions taking
place in the system and Car undergoes rapid oxygenation. Se-
ven products of this oxygenation have been identified by RP-
-HPLC. They accumulate up to six oxygen atoms, while reta-
ining the C40 skeleton. The structural assignments, by MS and
2D-NMR show appearance of stable, cyclic mono- and di-en-
doperoxides of Car as products of this chemical quenching
of singlet oxygen by Car. The resultant endoperoxides are able
to promote both the autooxidation and perhaps the oxidation
of other species, as the (auto)oxygenation of Car continues in
the dark after initial irradiation. Such reactions could be
of a great importance in living tissues, where harmful lipid pe-
roxidation may take place in spite of, or under certain condi-
tions, even due to the presence of carotenoids.
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Generation and phenotyping of the
beta-carotene 15,15’;-monooxygenase
KO mouse
A. Eichinger, R. Goralczyk, A. Wyss
Human Nutrition and Health, DSM Nutritional Products Ltd.,
Basel, Switzerland
Beta-carotene 15,15;-monooxygenase (BCMO1) is
the main enzyme converting the provitamin A carotenoids to
retinal. By homologous recombination one allel was mutated
in the ES cells. The targeted mutation was then established in
the germline and gave rise to the new mouse strain: B6;129S6-
-Bcmo1tm1DNP. Homozygous offspring was viable and deve-
lopment and growth were comparable with wild type control
mice. To assess a possible beta-carotene (bc) effect indepen-
dently from its provitamin A activity we investigated the effect
of bc supplementation and depletion — over more than 100
days — in vitamin A-depleted BCMO1 knockout (KO) and
control mice. Mouse body weight was similar between KO and
control animals. HPLC analysis of liver and plasma for retinol
and bc in KO mice fed a high dose of bc showed tremendous
bc accumulation (35 times) compared to their control litter-
mates. Interestingly we also detected little retinol in liver
as well as in plasma from KO mice maintained on vitamin A defi-
cient diet and supplemented with bc. More surprisingly we
observed a strong homogeneous orange colour of the whole
body of the KO mice fed this high bc diet (especially skin, adi-
pose tissue and intestine). This phenotype clearly proves that
no or only a truncated form of BCMO1 is expressed in these
mice. The small amounts of retinol detected in liver and plas-
ma may be explained by excentric cleavage of bc. Lack of
BCMO1 might influence the expression of other genes invol-
ved in bc metabolism.
Lutein, zeaxanthin and lipids
as risk and protection factors
of age-related macular degeneration
M. Drobek-Słowik, K. Safranow, K. Jakubowska,
M. Rać, D. Karczewicz, D. Chlubek
Department of Ophthalmology, Pomeranian Medical University,
Szczecin, Poland, Department of Biochemistry and Chemistry,
Pomeranian Medical University, Szczecin, Poland
Objective: Age-related macular degeneration (AMD) is the
leading cause of blindness among people older than 65 years
of age. Lutein (LUT) and zeaxanthin (ZEA) are the only caro-
tenoids found in macular pigment. They protect the retina from
photochemical damage. The main purpose of the study was to
assess associations between concentrations of plasma lutein,
zeaxanthin and serum lipid fractions and different types of AMD.
We also planned to investigate if serum lipids correlate with
plasma concentrations of lutein and zeaxanthin.
Material and methods: We examined 215 persons 45 to
94 years of age. Fundus fluorescein angiography and macular
photographs were used to divide participants into non-neova-
scular case group (N-NV) (n = 92) and neovascular case gro-
up (NV) (n = 55). Controls (group C) (n = 68) for AMD cases
were age- and gender-adjusted persons without any retinal pa-
thology.Plasma carotenoid levels were determined by HPLC
and expressed as microgram/L. Serum lipid (total, LDL, HDL
cholesterol, triglycerides) concentrations were measured en-
zymatically and expressed as mg/dL. Kruskal-Wallis ANOVA,
U Mann-Whitney test and Spearman rank correlation coeffi-
cient were used in statistical analysis.
Results: A significantly lower mean ZEA levels were found
in group N-NV compared to controls (16 vs. 22.2; p < 0.004).
Group NV had significally lower LUT (92 vs. 127.6; p < 0.00001)
as well as ZEA (13.2 vs. 22.2; p < 0.004) concentration in com-
parison to C group. We found no statistically significant diffe-
rences in lipid levels between N-NV and C group. Concentra-
tions of total (202.9 vs. 221.5; p < 0.0067) and LDL choleste-
rol (126.4 vs. 147.7; p < 0.001) were significally lower, and
triglicerydes (153.2 vs. 136.9; p < 0.02) significally higher in
the group NV compared to controls. We also noted positive
correlations between carotenoids (LUT, ZEA) and total
(Rs = +0.27 and +0.27 respectively, p < 0.0001), LDL
(Rs = +0.29 and +0.3, p < 0.0001), and HDL cholesterol (Rs
= +0.23, p < 0.001 and +0.15, p < 0.03). Triglycerides were
negatively related to LUT and ZEA concentrations (Rs =
= –0.19 and –0.19, p < 0.01).
Conclusions: The findings suggest that higher plasma xan-
thophyll concentrations are associated with decreased risk
of AMD. The data reveal that hypercholesterolemia is not a risk
factor of AMD. Only high concentrations of triglycerides may
be related to increased risk of AMD. Positive correlations be-
tween carotenoids concentrations and rich in cholesterol lipid
fractions (LDL, HDL) may reflect the fact, that xanthophylls are
transported by the lipoproteins. The known cardiovascular risk
factor may be protection factor of AMD, because of its role in
carotenoid metabolism.
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Differences in all-trans beta-
-carotene (BC) uptake and eccentric
cleavage by human endothelial and
neoplastic cell lines
J. Hartwich1, J. Zagajewski2, A. Polus1, J. Dulińska2,
T. Sacha3, G. Riss4, J. Grzybowska1, M. Mikołajczyk1,
P. Laidler2, I. Wybrańska1, R. Goralczyk4,
A.B. Skotnicki3, A. Dembińska-Kieć1
1Department of Clinical Biochemistry and Laboratory
Diagnostics Jagiellonian University Medical College, Kraków,
Poland, 2Department of Medical Biochemistry Jagiellonian
University Medical College, Kraków, Poland, 3Chair and
Department of Haematology, Jagiellonian University Medical
College, Kraków, Poland, 4DSM Nutritional Products Ltd.,
R&D, Human Nutrition and Health, Basel, Switzerland
In vitro culture of  various cell lines serves as an important
model for investigation of the biological activity of beta-caro-
tene (BC). This effect depends on cellular uptake and metabo-
lism of beta-carotene. This study was aimed to investigate
the ability of the different human cell lines to BC uptake and
metabolism by the eccentric cleavage and oxidation. The hu-
man normal cell line HUVEC (human umbilical vein endothe-
lial cells) and human neoplastic cell lines (leukemia, prostate
and melanoma) were exposed to all-trans beta-carotene. 3 mM
beta-carotene was supplemented alone or in combination with
3 mM arachidonic acid (AA) to HUVEC, HL60, WM35, A375,
PC-3 and LNCaP cell lines. In the second medium, 10 mM beta-
-carotene was supplemented alone or in combination with
3 mM AA to HL60, TF-1, U937, WM35, A375, PC-3 and LNCaP
cell lines. The incubation time was 24 hours, 48 hours and
72 hours. Both medium as well as cell lysates after extraction
were analysed by HPLC for the BC and its metabolite content.
Cellular BC content in response to supplementation with beta-
-carotene alone (AUC BC) or in combination with arachidonic
acid (AUC BC/AA) at three time intervals was calculated as
the area under the curve (AUC). Eccentric cleavage and oxi-
dation products formed from beta-carotene i.e. beta-carote-
ne-monoepoxide content (Epoxide ratio), and sum of 12’-apo-
carotenal, 8’-apocarotenal and 4’-b-apocarotenal (Apo ratio),
were expressed as the percent of the total cellular all-trans
beta-carotene. Significant differences in BC accumulation be-
tween the various cell types. led to following categorization:
L — low BC uptake, M — medium and H — high beta-carote-
ne uptake according to AUC value of the cellular BC content:
L: < 25th percentile, M: < 25th AUC < 50th percentile and
H: > 50th percentile respectively. In several cell lines AA au-
gmented the cellular BC uptake. HUVEC and human promy-
elocytic leukemia HL-60 cell line were classified to L group.
Human myelomonocytic U937 cells and human erythroleuke-
mic TF-1 cell line were classified to medium-uptake group.
The melanoma cell lines: WM 35 from a primary radial growth
Susceptibility of lipids from different
flax cultivars to peroxidation and
its lowering by added antioxidants
A. Krasowska, J. Szopa, M. Lukaszewicz
Biotransformation Unit, Institute of Genetics and Microbiology,
Wroclaw University, Wroclaw, Poland, Institute of Biochemistry
and Molecular Biology, Wroclaw University, Wroclaw, Poland
Consumption of flax (Linum usitatissimum) seeds is benefi-
cial for human health. Flax seeds containing about 40% of oil
are the richest, among crop plants, source of polyunsaturated
fatty acids (PUFA) essential in human diet. PUFA are highly
susceptible to oxidation, thus only certain cultivars (eg. Linola)
with low linolenic acid content are suitable for commercial pre-
paration of edible oil, which has, nevertheless, a very short
shelf life. To study the factors influencing flax oil stability, oil
has been extracted from nine flax cultivars and analyzed. Lino-
la contained about 3% of linolenic acid, while in other analy-
zed cultivars its content ranged from 52 to 73%. Instead, Li-
nola is rich in linoleic acid (about 75%) which in others culti-
vars varied from 12 to 18%. The susceptibility to oxidation of
extracted oil has been analyzed using two methods (conjuga-
ted dienes and malondialdehyde formation). Even the low li-
nolenic acid content Linola oil was easily oxidized. The most
resistant to peroxidation was oil extracted from Abby.
The potential to reduce peroxidation has been tested using
antioxidants (beta-carotene and quercetine) at the concentra-
tions ranging from 10 to 250 mM. The formation of thiobarbi-
turic acid reactive substances (TBARS) was most efficiently
reduced by 25 mM of both beta-carotene and quercetine. Hi-
gher concentrations of beta-carotene increased level of TBARS.
The efficiency of beta-carotene and quercetine varied depen-
ding on analyzed cultivar probably due to intrinsic content of
antioxidants.
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phase lesion, and A375 from metastatic sites as well as the
prostate cancer cell lines: LNCaP and the androgen-sensitive
PC-3, represented high-uptake group for both beta-carotene
concentrations. Combined supplementation i.e. arachidonic
acid with beta-carotene, reversed the uptake relation betwe-
en both prostate cell lines and melanoma lines. A significant
inverse correlation between beta-carotene uptake (AUC BC)
and Epoxy ratio and Apo ratio was observed in all cells, at both
BC concentrations used. In summary, we found that BC disso-
lved in freshly purified THF in “pharmacological” , non-toxic
concentrations is differentially absorbed by cell lines. Cells with
low BC uptake (endothelial and leukemia cells) are characteri-
zed by a higher BC catabolism rate in comparison to cells with
high BC uptake such as prostate carcinoma and melanoma.
The authors thank the DSM Nutritional Products for support.
This work was supported by the EU Project QLK1-CT-2001-
-00183 - DLARFID (Dietary Lipids as Risk Factors in Development.
Mechanistic Issues) and Polish State Research Grant No 501/P/180/L.
Effects of dietary lycopene on lipid
parameters and yolk coloration
in Japanese quail
L. Bárdos, K. Réthy, Z. Kiss, C. Szabó
Department of Animal Physiology and Health, University
St. István, Gödöllo, Hungary
Lycopene is a member of the carotenoid family as an acyc-
lic isomer of beta-carotene but has no vitamin A activity. This
pigment is responsible for the red color of tomato and its pro-
ducts. Beside the coloration effects lycopene has one of the
highest antioxidant activity of all the carotenoids but non-an-
tioxidant mechanisms have also been proposed such as upre-
gulation of gap junction protein expressions, suppression
of phosphorylation, inhibition of cholesterol synthesis and cell
division. Because lycopene may have some health benefits a lot
of studies focused its effects. Most of the studies deal with the
aspects of human health (i.e. prostate and lung cancer) and less
in animal science. Some effects of lycopene were investigated in
model experiments on Japanese quails by our group.
The effects of yolk coloration, some parameters of lipid meta-
bolism and antioxidant status and non challenged avian immu-
noglobulin (IgY) titers were investigated of quails kept on fod-
der containing natural originated lycopene supplement in the
form of tomato concentrate for 4 weeks. According the results
lycopene has a valuable pigmentation effect of egg yolk. Plasma
and liver cholesterol decreased in lycopene supplemented ani-
mals. The antioxidative status was evaluated using thiobarbitu-
ric acid--reactive substance (TBARS) and ferro-reducing ability
of plasma (FRAP) methods. These parameters and the IgY titers
were not changed markedly. We can conclude that the lycope-
ne containing tomato produce, maybe some by-product of pro-
cessing could be use as beneficial factor in the poultry nutrition.
Beta-carotene and cigarette smoke:
a chemical and biological approach
K. Vlismas, F.C.R. Manning, G.M. Lowe
Biomolecular Sciences, Liverpool John Moores University,
Liverpool, United Kingdom
Human intervention trials have shown that supplemental
beta-carotene increases cancer risk in smokers but the me-
chanism underlying this effect is still unknown. The chemical
and biological effect of cigarette smoke and beta-carotene are
poorly understood. Only a relatively small number of studies
have attempted to determine the degradation pathways in-
volved when beta-carotene is challenged with cigarette smoke
(and in particular identifying the products of such reactions).
The aims of this study were to establish the oxidation products
formed when beta-carotene was exposed to cigarette smoke
and to investigate the effect on cell growth and apoptosis on
two human lung cell lines a) when cells are exposed to beta-
-carotene and cigarette smoke and b) when beta-carotene has
previously been oxidised by cigarette smoke. Beta-carotene
was exposed to filtered cigarette smoke and its oxidation pro-
ducts were analysed using a HPLC employing a C30 reversed-
phase YMC column with diode array detection. The chemical
structure of these components was determined by LC-MS and
by GC-MS analysis. Two different human lung cell lines (CORL-
-24 and NCIH-727) were exposed to cigarette smoke in com-
bination with beta-carotene and also to beta-carotene that has
been previously oxidised by cigarette smoke at concentrations
of 1, 5 and 10 mM respectively. Oxidation using whole cigaret-
te smoke resulted in considerable bleaching of beta-carotene
coupled with the presence of a range of oxidation products be-
ing detected including 4-nitro-beta-carotene, cis-isomers and low
molecular volatile oxidation products such as beta-cyclocitral,
beta-ionone and 5, 6 epoxy-beta-ionone. The first exposure
of transformed cells to beta-carotene and cigarette smoke re-
sulted in an inhibition of growth particularly when cells were
previously supplemented with higher doses of beta-carotene.
When only 1 mM beta-carotene was used it exhibited less inhibi-
tion of growth compared to the cells only exposed to smoke.
It seems to suggest that the combination of cigarette smoke and
beta-carotene has a major effect in promoting the apoptosis
of these cells with the lower dose of beta-carotene being more
protective against apoptosis, when exposed to cigarette smoke.
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Chemical composition of dried
biomass of Blakeslea trispora
E. Kunschikova, V. Narushin, I. Kunschikova,
A. Tyurenkov
Vitan Ltd., Dnepropetrovsk region, Ukraine, Vita-Market Ltd.,
Zaporozhye, Ukraine
The problem of obtaining of natural carotenoids from re-
latively cheap sources of raw materials is rather important now.
One of super-producers of beta-carotene is a mucor fungus
Blakeslea trispora, processed commercially by microbiological
synthesis. Besides beta-carotene, products of processing of the
fungus are rich in other vitamins, polyunsaturated fatty acids,
minerals, micro- and macro-elements. The objective of the
present research was the definition of chemical composition
of products of processing of the fungus Blakeslea trispora.
The materials for the investigations were the products, com-
mercially produced by the research and production enterprise
„VITAN” (Dnepropetrovsk region, Ukraine): the dried biomass
and products of its extraction, i.e. the beta-carotene oil solu-
tion (0.2% of pure beta-carotene) and beta-carotene suspen-
sion in fat (30% of pure beta-carotene). The analyses were
carried out in the Institute of Biochemistry (Kiev, Ukraine).
It was determined, that the biomass contains from 4 up to 9%
of beta-carotene. Besides beta-carotene, the biomass contains
vitamins B1 (0.1–0.2 mg%), B2 (0.2–0.9 mg%), B6 (0.7–0.9
mg%), B9 (0.35–0.45 mg%), C (20–25 mg%), PP (1–1.5
mg%), E (15–28 mg%). The phenotypic correlation between
the percentage of beta-carotene in the biomass and some vita-
mins has been investigated: B1 (r = –0.62), B2 (r = 0.98), B6
(r = 0.98), B9 (r = 0.38), C (r = 0.41), E (r = 0.24).
The biomass also contains the following esential fatty acids:
oleinic (~30%), linolic (~50%), linolenic (~0,5%), arachido-
nic (~0,2%); and free amino acids: glutamic (~12 mg%), lysi-
ne (~10 mg%), leucine (~8 mg%), valine (~6 mg%), isoleu-
cine (~5 mg%), glutamine (~5 mg%), phenyl alanine
(~5 mg%). The investigation of the oil solutions showed the
high correlation (r = 0.98) between the beta-carotene per-
centage and vitamin E. Besides vitamin E, the oil solutions con-
tain B6 (0.62 mg%), B9 (0.16 mg%), PP (1 mg%). In fatty acid
composition the linolic (~60%) and oleinic (~30%) acids pre-
vailed. Besides these, the palmitic (~7%), arachidonic (~1%)
and linolenic (~0,5%) acids have been defined.Thus, it is po-
ssible to conclude, that the products of processing of the fun-
gus Blakeslea trispora besides the ability to produce beta-caro-
tene, are depositors of a unique polyvitaminic complex that
makes these valuable edible and fodder preparations.
Profiles of lipids in fruit-bodies
of some edible mushrooms
 K. Grzywnowicz
Department of Biochemistry, UMCS, Lublin, Poland
The lipids important in nutrition are of three classes: tri-
glycerides (called fats), phospholipids, and sterols. The predo-
minant lipids in foods are triglycerides, and sterols and their
esters. Fatty acids vary in the length of their carbon chains,
their degree of unsaturation, and location of their double
bond(s). Mushrooms as food are a valuable source of vitamins
(mainly of B group and C), micro elements, and protein (con-
tent of proteins is low, but of high quality (NPU) and amino
acids profile, close to animal proteins). Also content of fiber
(chitin, lowering level of animal sterols and triglycerides in
digested foods, as well as polysaccharides, substances of medi-
cinal value) is appropriate for diet. Hard-digestibility is, for ac-
tual knowledge, rather a myth derived from mycophoby of parts
of Europe and North America. So we decide to investigate
rather a weekly known problem of lipid profiles of edible mu-
shrooms. In the material presented, we analyzed contents
of various types of lipids in fruit-bodies of edible mushrooms:
tree wilde specia (Boletus edulis, Cantharellus cibarius, and Ar-
milariella mellea — wood-degrading one) and four cultivated
specia (Agaricus bisporus — saprotrophic one, and Lentinus edo-
des, Pleurotus ostreatus and Pholiota nameko — wood-degra-
ding ones). We confirm that content of crude fat in mushro-
oms is relatively low (2–9%), higher in wood-degrading spe-
cia. In fatty acids we demonstrated presence of omega-6 acids
(mainly linoleic acid). In complex lipids we obtained high con-
tent of cerebrosides, valuable for their biological activity.
In sterols main constituents were, according to species, ergo-
sterol (and vitamin D2 derivatives), fungisterol, brassicasterol,
lanosterol (and lanostan derivatives), squalen, and triterpene
acids. The last ones are especially of great medicinal value and
have potential pharmacological activity. Our investigations con-
firmed the dietary and medicinal value of mushrooms as func-
tional foods and nutraceuticals, also in scope of dietary lipids.
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and animal research must gain acceptance of the local ethi-
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PREPARATION OF MANUSCRIPTS
These guidelines are in accordance with the Uniform Require-
ments for Manuscripts Submitted to Biomedical Journals (The
complete document appears in N. Engl. J. Med. 1997; 336:
305–315).
Manuscript should be typed on white bond paper. Margins
should be no less than 3 cm, each page should contain no
more 30 lines. Double spacing should be used throughout the
manuscript including the following sections, each of which
should begin on a separate sheet: title page, summary and
key words, text, acknowledgements, references, individual
tables and figures. Pages should be numbered consecutively,
beginning with the title page. Abbreviations, if used, should
be defined on their first appearance in the text and those not
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Original articles should have the following structure:
Title page. The title page should carry the full title of the pa-
per and a short title, consisting of not more than 40 charac-
ters including spaces, to be used as a running head (and
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of the author responsible for correspondence concerning the
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of any support for the work in the form of grants, equipment
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Abstracts. Provide on a separate page an abstract of not more
than 250 words. Articles containing original data should in-
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labeled: Background, Material and Methods, Results, and
Conclusions. The abstract should be followed by a list of
3–10 key words or short phrases. When possible, the terms
used should be from the Medical Subject Headings list of the
Index Medicus.
Text. Full papers of an experimental or observational nature
may be usefully divided into sections headed: Introduction,
Methods, Results and Discussion, although reviews may
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for a specific type of article: original article –– 3000 words,
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letters — 1000 words (not including abstract, tables and ref-
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ZASADY EDYCJI ORAZ INFORMACJE OGÓLNE
Czasopismo Acta Angiologica (nazywane dalej AA) jest ofi-
cjalnym pismem Polskiego Towarzystwa Angiologicznego
oraz Polskiego Towarzystwa Chirurgii Naczyniowej, w którym
są publikowane recenzowane artykuły poglądowe, oryginal-
ne prace badawcze dotyczące angiologii, prace kazuistycz-
ne (opisy przypadków), listy, recenzje książek oraz komenta-
rze redakcyjne.
Redakcja AA przestrzega zasad zawartych w Deklaracji Hel-
sińskiej i oczekuje, że badania dotyczące ludzi zostały prze-
prowadzone zgodnie z tymi zasadami. W przypadku badań
z wykorzystaniem modeli zwierzęcych redakcja oczekuje
przestrzegania zasad zawartych w Interdisciplinary Principles
and Guidelines for the Use of Animals in Research, Testing
and Education wydanych przez New York Academy of Scien-
ces’ Adhoc Committee on Animal Research. Wszystkie pra-
ce odnoszące się do ludzi lub zwierząt muszą być zaakcep-
towane przez odpowiednią lokalną Komisję Etyczną, co na-
leży zaznaczyć w tekście.
Zasady recenzowania prac. Nadesłane prace ocenia się pod
względem takich wartości, jak nowatorskie przedstawienie te-
matu, znaczenie dla dalszego rozwoju badań naukowych oraz
dla postępowania klinicznego. Nadesłane manuskrypty wstęp-
nie ocenia redakcja AA. Prace niespełniające podstawowych
warunków publikacji są odrzucane. Manuskrypty niekomplet-
ne lub przygotowane w stylu niezgodnym z zasadami podany-
mi poniżej redakcja odsyła autorom bez oceny merytorycznej.
Pozostałe artykuły zostają zarejestrowane i są następnie prze-
kazywane do oceny niezależnych recenzentów. Decyzję o za-
kwalifikowaniu manuskryptu do publikacji Redakcja przesyła
do autorów wraz z podaniem numeru referencyjnego, którego
należy używać w trakcie dalszych kontaktów z Wydawcą.
Zachęca się autorów do wskazywania nazwisk recenzentów,
jednak redakcja zastrzega sobie jednak prawo ostatecznego
ich wyboru. Akceptacja do druku odbywa się na podstawie po-
zytywnych opinii recenzentów.
Konflikt interesów. Jednocześnie ze złożeniem manuskryp-
tu, autorzy prac badawczych są zobowiązani do ujawnienia
wszelkich zobowiązań finansowych, jeżeli takie istnieją, po-
między autorami a firmą, której produkt ma istotne znacze-
nie w nadesłanej pracy, lub firmą konkurencyjną. Informacje
te nie będą ujawniane recenzentom i nie wpłyną na decyzje
o opublikowaniu pracy. Po akceptacji manuskryptu do dru-
ku Redakcja zwykle omówi z autorami formę, w jakiej infor-
macje o źródłach finansowania powinny zostać udostępnio-
ne czytelnikom.
W związku z tym, że artykuły przeglądowe i komentarze re-
dakcyjne polegają na wyborze i interpretacji danych z dostęp-
nego piśmiennictwa, Redakcja AA oczekuje, iż autorzy tego
typu opracowań będą wolni od finansowych związków z fir-
mami, których produkty są przedmiotem artykułu (lub z fir-
mami konkurencyjnymi).
Wymaga się, by recenzenci, członkowie redakcji, zastępcy
Redaktora Naczelnego ujawnili w liście do Redaktora Naczel-
nego wszelkie zobowiązania i okoliczności mogące wpłynąć
niekorzystnie na proces wydawniczy manuskryptu podlega-
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Zasady edycji oraz informacje dla autorów
jącego recenzji. List ten powinien zawierać oświadczenie
o jakichkolwiek powiązaniach finansowych (o ile takie istnieją)
z firmą produkującą lek będący przedmiotem publikacji.
Ewentualne spory z Wydawcą dotyczące publikacji będą roz-
strzygane przez Sąd Rejonowy właściwy dla siedziby Wydaw-
cy. Stosunki prawne łączące Wydawcę i autora podlegają pra-
wu polskiemu i obowiązującym Polskę konwencjom między-
narodowym.
Pozwolenie na druk. Do materiałów poprzednio opublikowa-
nych należy dołączyć pisemną zgodę na ponowne wydanie,
zarówno od poprzedniego wydawcy, jak i autorów oryginalnej
pracy. Jeżeli informacje zawarte w opisie przypadku, na ilustra-
cji lub w tekście pracy oryginalnej pozwalają na identyfikację
osób, należy dostarczyć ich pisemną zgodę na publikację.
Przekazanie praw autorskich. Przesyłając maszynopis wraz
z ilustracjami i tabelami, autor (autorzy) oświadcza (oświad-
czają), że nadesłana praca nie była uprzednio publikowana ani
nie została złożona do redakcji innego czasopisma (z wyłącze-
niem streszczeń nie przekraczających 400 słów). Ponadto
oświadcza, że automatycznie i nieodpłatnie przenosi wszelkie
prawa autorskie do wydawania i rozpowszechniania nadesła-
nych materiałów we wszystkich znanych formach i na wszyst-
kich znanych polach eksploatacji na Wydawcę, pod warunkiem,
że materiały te zostaną zaakceptowane do publikacji. Jedno-
cześnie zgadza się, że praca nie zostanie opublikowana gdzie-
kolwiek i w jakimkolwiek języku bez wcześniejszej pisemnej
zgody nabywcy praw autorskich, jakim jest Wydawca.
Zastrzeżenie. Redakcja oraz Wydawca dokładają wszelkich
starań, by informacje opublikowane w AA były wiarygodne
i dokładne. Jednakże opinie wyrażane w artykułach czy re-
klamach publikuje się na wyłączną odpowiedzialność auto-
rów, sponsorów lub reklamodawcy. W związku z tym ani Re-
dakcja, ani Wydawca nie ponoszą odpowiedzialności za kon-
sekwencje wykorzystania jakichkolwiek nieścisłych informa-
cji. Dawki leków i inne wartości liczbowe są sprawdzane z na-
leżytą starannością, jednak wszelkie schematy leczenia opi-
sywane w AA należy stosować zgodnie z informacjami o leku
publikowanymi przez producenta.
PRZYGOTOWANIE MANUSKRYPTU
Regulamin zgłaszania artykułów do druku opracowano na
podstawie “Uniform Requirements for Manuscripts Submitted
to Biomedical Journals” N. Engl. J. Med. 1997; 336: 309–315.
Maszynopis, w języku angielskim i polskim, powinien być dru-
kowany jednostronnie na białym papierze formatu A4, z po-
dwójnym odstępem linii. Marginesy nie mogą być mniejsze
niż 3 cm, a strona nie powinna zawierać więcej niż 30 wier-
szy. Każda z części maszynopisu powinna zaczynać się na
nowej stronie: strona tytułowa, streszczenie (angielskie i pol-
skie), słowa kluczowe (angielskie i polskie), tekst, podzięko-
wania, piśmiennictwo, tabele i ryciny. Kolejne strony należy
ponumerować, zaczynając od strony tytułowej. Skróty, wraz
z rozwinięciem, należy podać w nawiasie za skracanym okre-
śleniem przy pierwszym jego wystąpieniu w tekście. Należy
unikać skrótów nieakceptowanych przez międzynarodowe
grupy ekspertów.
Prace powinny mieć następującą strukturę:
Strona tytułowa. Powinna zawierać: pełny tytuł pracy (angiel-
ski i polski), tytuł skrócony (angielski i polski), zawierający mak-
simum 40 znaków (łącznie z odstępami), imiona i nazwiska
wszystkich autorów oraz tytuły naukowe, nazwę instytucji, z któ-
rej pochodzi praca, imię i nazwisko, adres, numer telefonu i fak-
su autora odpowiedzialnego za korespondencję z redakcją. Po-
nadto należy umieścić informację o grantach i innych źródłach
finansowania oraz aktualne miejsce pracy autorów.
Streszczenie (angielskie i polskie). Nie powinno zawierać
więcej niż 250 słów. W streszczeniu pracy oryginalnej należy
wyodrębnić cztery akapity zatytułowane: Wstęp, Materiał
i metody, Wyniki, Wnioski. Pod streszczeniem należy umie-
ścić od 3 do 10 słów lub wyrażeń kluczowych (angielskich
i polskich), w miarę możliwości zgodnych z Medical Subject
Headings Index Medicus.
Tekst. Prace oryginalne należy podzielić na następujące czę-
ści: Wstęp, Materiał i metody, Wyniki, Dyskusja, Wnioski.
Prace poglądowe mogą być podzielone w inny sposób. Nie
należy przekraczać zalecanych objętości prac: praca orygi-
nalna — 3000 słów, poglądowa –– 6000 słów, opis przypad-
ku — 2000 słów, list — 1000 słów. Przedstawione limity nie
obejmują streszczenia, tabel, piśmiennictwa. Dodatkowe in-
formacje i podziękowania mogą się znaleźć po zakończeniu
tekstu, przed wykazem piśmiennictwa.
Piśmiennictwo. Należy drukować z podwójnym odstępem,
pozycje ponumerowane zgodnie z kolejnością cytowania
w tekście (nie w porządku alfabetycznym).
Czasopisma. W wypadku cytowanych czasopism należy po-
dać: kolejny numer pozycji, nazwiska autorów i pierwsze lite-
ry imion (jeśli autorów jest nie więcej niż sześciu, należy wy-
mienić wszystkich, jeśli siedmiu i więcej, należy podać trzech
pierwszych z dopiskiem ”et al.”, rok wydania, tytuł pracy, tytuł
czasopisma (skróty tytułów czasopism powinny być zgodne
z Index Medicus), tom (cyframi arabskimi), numer strony po-
czątkowej i końcowej. Prosimy nie używać określeń: „w dru-
ku”, „w przygotowaniu”, „informacja ustna” –– w uzasadnio-
nych wypadkach można je zastosować w odpowiednim miej-
scu w tekście.
Przykład
Eliasson M, Jansson J, Nilsson P, Asplund K (1997) Increased
levels of tissue plasminogen activator antigen in essential
hypertension. A population-based study in Sweden. J Hyper-
tens, 15: 349–356.
Książki. W wypadku cytowanych książek należy wymienić: ko-
lejny numer pozycji, nazwiska autorów, rok wydania, tytuł, wy-
dawcę, miejsce wydania. Powołując się na treść rozdziału
książki, należy podać: nazwisko autora, inicjały imion, rok
wydania, tytuł rozdziału, nazwisko autora (redaktora) książki,
inicjały imion, tytuł książki, wydawcę, miejsce wydania, prze-
dział stron.
Przykład, gdy autor i redaktor są różnymi osobami: Rosen
MR (1992) Principles of cardiac electrophysiology. In: Kelley
W.N. (ed.) Internal Medicine. J.B. Lipipincott Company, Phi-
ladelphia, 90–95.
Przykład, gdy autor jest redaktorem: Braunwald E (1992)
Heart Disease. W.B. Saunders Company, Philadelphia,
393–418.
Tabele, ryciny, fotografie. Powinny być czarno-białe, ponu-
merowane, wydrukowane na osobnych kartkach. Fotografie:
czarno-białe, trzy odbitki, na błyszczącym papierze, format od
13 ¥ 18 cm do 15 ¥ 20 cm, o jakości gwarantującej czytel-
ność po dwukrotnym zmniejszeniu wielkości. Na odwrocie foto-
grafii i rycin należy zaznaczyć: numer zgodny z kolejnością za-
mieszczania w tekście, nazwisko pierwszego autora, początek
tytułu; należy też wskazać górną część. Opisy tabel, rycin i foto-
grafii powinny być drukowane na oddzielnych kartkach (po an-
gielsku i po polsku). Materiały ilustracyjne poprzednio publi-
kowane należy zaopatrzyć w pisemną zgodę Wydawcy na po-
nowną publikację.
Elektroniczny zapis manuskryptu. Prosimy autorów o prze-
kazywanie tekstów z wykorzystaniem powszechnie używa-
nych edytorów tekstu. Zalecane jest stosowanie standardo-
wych czcionek o rozmiarze 12 punktów.
WYSYŁANIE MANUSKRYPTU DO REDAKCJI
Prace należy przesłać w trzech egzemplarzach (oryginał i dwie
kopie), łącznie z trzema kopiami ewentualnych tabel, rycin czy
zdjęć oraz na dyskietce 3,5”, na której powinien być podany
zastosowany format oraz nazwa programu. Wydruki tabel i fo-
tografie należy zabezpieczyć tak, aby nie doszło do ich znisz-
czenia. Fotografie i folie powinny znajdować się w osobnej
grubej kopercie.
Autorzy mający dostęp do Internetu mogą przesłać materiały
do publikacji pocztą elektroniczną. Używany program pocz-
towy powinien umożliwiać dołączanie plików do przesyłanej
informacji. Zaleca się, aby poszczególne części pracy (tekst,
ilustracje, tabele, zdjęcia itp.) były wysyłane jako oddzielne
pliki. Aby usprawnić przesyłanie danych należy dokonać ich
kompresji za pomocą formatów *.arj lub *.zip.
Do każdego maszynopisu należy dołączyć list przewodni
stwierdzający, że:
a) praca nie została opublikowana ani nie została złożona
do innej redakcji;
b) praca została zaaprobowana przez wszystkich współauto-
rów i kierownictwo ośrodków, w których powstała;
c) autor (autorzy) zgadza (zgadzają) się na automatyczne
i nieodpłatne przeniesienie wszelkich praw autorskich na
Wydawcę w momencie zaakceptowania materiałów do
publikacji;
d) ujawniono wszelkie źródła finansowania;
e) autor (autorzy) zna (znają) zasady edycji i informacje dla
autorów ogłaszane w „Acta Angiologica” i będzie (będą)
ich przestrzegać;
f) autor (autorzy) jest gotów (są gotowi) pokryć ewentualne
koszty wydrukowania kolorowych ilustracji (100 USD za
stronę).
Schemat listu przewodniego jest dostępny pod adresem:
www.angiologia.pl
Korespondencję zawierającą materiały do publikacji należy
wysłać na adres:
Redakcja
Acta Angiologica
Katedra i Klinika Chirurgii Ogólnej
Szpital Wojewódzki im. dr. J. Biziela
ul. K. Ujejskiego 75, 85–168 Bydgoszcz
tel./faks: +48 (0 52) 371 57 82
e-mail: ajawien@ceti.com.pl
